The University of Southern Mississippi

The Aquila Digital Community
Dissertations

Fall 12-2014

Characterization and Role of MSAABCR in Biofilm
Development and Virulence in Staphylococcus
aureus
Gyan Sundar Sahukhal
University of Southern Mississippi

Follow this and additional works at: https://aquila.usm.edu/dissertations
Part of the Microbiology Commons, and the Molecular Biology Commons
Recommended Citation
Sahukhal, Gyan Sundar, "Characterization and Role of MSAABCR in Biofilm Development and Virulence in Staphylococcus aureus"
(2014). Dissertations. 21.
https://aquila.usm.edu/dissertations/21

This Dissertation is brought to you for free and open access by The Aquila Digital Community. It has been accepted for inclusion in Dissertations by an
authorized administrator of The Aquila Digital Community. For more information, please contact Joshua.Cromwell@usm.edu.

The University of Southern Mississippi

CHARACTERIZATION AND ROLE OF MSAABCR IN BIOFILM DEVELOPMENT
AND VIRULENCE IN STAPHYLOCOCCUS AUREUS

by
Gyan Sundar Sahukhal

Abstract of Dissertation
Submitted to the Graduate School
of The University of Southern Mississippi
in Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy

December 2014

ABSTRACT
CHARACTERIZATION AND ROLE OF MSAABCR IN BIOFILM DEVELOPMENT
AND VIRULENCE IN STAPHYLOCOCCUS AUREUS
by Gyan Sundar Sahukhal
December 2014
Community-acquired, methicillin-resistant Staphylococcus aureus strains often
cause localized infections in immune-compromised hosts, but some strains show
enhanced virulence leading to severe infections even among healthy individuals with no
predisposing risk factors. The genetic basis for this enhanced virulence has yet to be
determined. S. aureus possesses a wide variety of virulence factors, the expression of
which is carefully coordinated by a variety of regulators. Several virulence regulators
have been well characterized, but others have yet to be thoroughly investigated.
Previously, the msa gene as a regulator of several virulence genes, biofilm development,
and antibiotic resistance was identified. The evidence of the involvement of upstream
genes in msa function was also observed. To investigate the mechanism of regulation of
the msa gene (renamed msaC), the upstream genes whose expression was affected by its
deletion was studied. Further study showed that msaC is part of a newly defined fourgene operon (msaABCR), in which msaC is a non-protein-coding RNA that is essential
for the function of the operon. Furthermore, the study also found an antisense RNA
(msaR) is complementary to the 5’ end of the msaB gene and is expressed in a growth
phase-dependent manner suggesting that it is involved in regulation of the operon.
One of the most important aspects of staphylococcal infections is biofilm
development within the host, which renders them resistant to the immune response and
ii

antimicrobial agents. Biofilm development is very complex and involves several
regulators that ensure cell survival on surfaces within the extrapoylmeric matrix. In this
study, the regulatory pathway that msaABCR uses to control biofilm formation was
identified. This study showed that the msaABCR operon is a negative regulator of
proteases. Control of protease production mediates processing of the major autolysin Atl
and therefore regulates rates of autolysis. In the absence of the msaABCR operon, Atl is
processed by proteases at a high rate, which leads to increased cell death and a defect in
biofilm maturation. This study also found that the msaABCR operon plays a key role in
maintaining the balance between autolysis and growth within staphylococcal biofilm.
These findings will allow defining a new operon that regulates fundamental
phenotypes in S. aureus such as biofilm development and virulence. Characterization of
the msaABCR operon will allow the investigation of the mechanism of function of this
operon and the role of the individual genes in regulation and interaction with its targets.
This study identifies a new element in the complex regulatory circuits in S. aureus, and
the findings may be therapeutically relevant.
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CHAPTER I
INTRODUCTION
Staphylococcus aureus
Staphylococcus aureus is a Gram-positive bacterium that frequently colonizes
25% of the human population and other warm-blooded animals. They primarily colonize
the anterior nares but can also potentially colonize on the throat, skin, axilla, perirectal
area, and groin area (Dall'Antonia et al., 2005; Kluytmans et al., 1997; Kuehnert et al.,
2006). S. aureus is an opportunistic pathogens and is associated with one of the most
common cause of healthcare and community-associated infections (Davis et al., 2007;
Klein et al., 2007; Ray et al., 2012). In the United States, S. aureus associated infections
have a mortality rate of 25% and are responsible for hospitalizations that are typically
twice the length as normal stays, thus, doubling the medical cost (Rubin et al., 1999;
Wenzel & Edmond, 2001). Predisposing risk factors like surgery, indwelling medical
devices, and immune-compromised conditions trigger healthcare associated
Staphylococcal infections. These infections typically includes bacteremia usually
transmission by hospital personnel who are transiently colonized with Staphylococcus
aureus (Herold et al., 1998). A major difficulty in the treatment of S. aureus infections is
because of their ability to acquire resistance to antibiotics. Over the last few decades, the
emergence of MRSA has spread worldwide and is now endemic in most hospitals or
healthcare facilities and has become one of leading causes of death in the United States
(DeLeo & Chambers, 2009; Klevens et al., 2007). MRSA infections were, however,
limited to hospital settings, until the emergence of Community Associated MRSA strains

2

of S. aureus that caused infections among healthy individuals, and outside the hospital
settings without any predisposing risk factors.
Emergence of Community Acquired Methicillin Resistant S. aureus (CA-MRSA)
CA-MRSA strains emerged in a community, not associated with the selective
pressure of the antibiotic treatment in the hospital settings. Since its first emergence in
Western Australia in 1990s (Udo et al., 1993), it has been spread worldwide and has now
already become an epidemic in the United States (Fridkin et al., 2005; Moran et al.,
2006). CA-MRSA strains were responsible for a dramatic increase in the incidence of
infections, particularly of the skin and soft tissue (Crum et al., 2006), and were the cause
of many unusually severe infections such as necrotizing pneumonia, necrotizing fasciitis,
and myositis (Charlebois et al., 2004; Huang et al., 2006; Kazakova et al., 2005). A
comparative study of CA-MRSA versus MSSA virulence has shown that CA-MRSA
strains are more virulent, spread very fast, and are more invasive and naturally produced
increased virulence factors. However, it is not yet clear if all CA-MRSA strains are
equally virulent (Miller et al., 2007; Sattler et al., 2002). But, one particular CA-MRSA
clone, USA300, has been proven the most successful strain (Young et al., 2004),
spreading rapidly, and has become the most dominant clone in most regions of the United
States. Many reports have linked USA300 to more severe infections of the bone, skin,
and soft tissue (Huang et al., 2006; Sattler et al., 2002).
Studies have shown that the USA300 evolved from a sub-lineage that is naturally
characterized by a phenotype of high virulence distinct from other MRSA strains.
USA300 originated from its progenitor, USA500 that had shown to be highly virulent in
animal infection models studies and had the capacity to evade innate host defense
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mechanisms. The increased virulence in the USA300/USA500 sublineage is attributable
to differential expression of core genome-encoded virulence determinants, such as
phenol-soluble modulins and toxin. Notably, the fact that the virulence phenotype of
USA300 was already established in its progenitor indicates that an acquisition of mobile
genetic elements has played a limited role in the evolution of USA300 virulence and
points to a possibly different role of those elements (Li et al., 2009).
Why S. aureus is a Successful Pathogen?
The ability of S. aureus to infect a variety of tissues is mainly attributed to its
ability to produce myriads of virulence factors that include both secreted proteins and
adhesins. These factors are categorized as surface-associated proteins, secreted proteases,
toxins (hemolysins, phenol-soluble, modulins), or immune modulators, which play an
important role in S. aureus dissemination and immune evasion. Surface-associated
virulence factors are typically members of the MSCRAMM (microbial surface
components recognizing adhesive matrix molecules) (Clarke & Foster, 2006). Protein A
(Spa), Elastin-binding protein (Ebp), Collagen binding protein, the fibronectin-binding
proteins A and B (FnbpAB), and the clumping factors A and B (ClfAB) are some
examples of MSCRAMM (Arciola et al., 2005; Clarke & Foster, 2006; Downer et al.,
2002; Gillaspy et al., 1998; Peacock et al., 2000). MSCRAMM molecules are covalently
attached to the cell wall peptidoglycan and are important for the attachment to the host’s
matrix proteins like collagen, fibronectin, and fibrinogen. MSCRAMMs are also
important for the initiation of endovascular infections, bone and joint infections, and
prosthetic device infections. Yet, this is not the complete lists of the virulence factors that
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contribute to the pathogenic potential of this bacterium (Clarke & Foster, 2006; Junecko
et al., 2012).
Another reason why this organism is so potent and successful is because of their
art of regulating the expression of various virulence factors in a very carefully
coordinated manner and by a variety of regulators network such as trans-acting global
regulators, alternative sigma factors, and small non-coding RNAs (Felden et al., 2011;
Junecko et al., 2012; Shaw et al., 2008). Indeed, the S. aureus genome has 124 putative
transcriptional regulators (Kuroda et al., 2001). Understanding virulence regulation
during growth under different environmental conditions (e.g., biofilm) is critical to the
prevention and treatment of S. aureus infections. To date, there are several global
regulators that have been identified, which include the agr operon, the sarA gene family,
the SaePQRS operon, and the genes arlRS, lytSR, srrAb, hssRS, vraSR, and graSR
(Brunskill & Bayles, 1996; Cheung et al., 1992; Cheung et al., 2008; Falord et al., 2011;
Fournier & Hooper, 2000; Gardete et al., 2006; Giraudo et al., 1994; Peng et al., 1988;
Torres et al., 2007; Yarwood et al., 2001). Several other regulators have also been
identified though they are not as well characterized (e.g., htrA, CcpA, MsrR, and SvrR)
(Mei et al., 1997; Moskovitz et al., 2002; Rigoulay et al., 2005; Seidl et al., 2006).
S. aureus Biofilm
One of the major factors responsible for the establishment of chronic infection by
S. aureus is their ability to form biofilm virtually on any host surfaces (Kiedrowski &
Horswill, 2011). They can form biofilms on host surfaces like hearth valves, bone (Brady
et al., 2008), cartilage, and medical implants like catheters and orthopedic devices
(Costerton et al., 2005; Parsek & Singh, 2003). Biofilm is a very well-organized
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microbial community encased in an extra-polymeric substances composed of
proteinaceous matrix, extracellular DNA and PNAG. This structure promotes the
bacterial persistence and offers protection from the innate immune system of the host and
other antimicrobials (del Pozo & Patel, 2007; Patel, 2005). Several factors like
extracellular matrix, reduced metabolic state of bacteria within the biofilm, and efficient
spread of antibiotic resistance mechanisms via gene transfer within the biofilm
community contribute to the biofilm recalcitrance.
Stages of Biofilm Development
S. aureus biofilm development occurs in several stages: Initial attachment,
accumulation, maturation, and dispersion (Figure 1). Initial attachment begins when the
individual planktonic cells attach to a substratum such as host tissue or any medical
implants. Several surface associated proteins (MSCRAMMs) and secreted proteins for S.
aureus bind with substratum coated with the human matrix proteins like fibronectin,
fibrinogen and collagens (Foster & Hook, 1998; Francois et al., 1998; Francois et al.,
2000). Following the initial attachment, the cells start to multiply to form a
microcolonies. The microcolonies then start producing the extrapolymeric substance,
communicate with each other via quorum sensing, and begin to form mature biofilm,
which is a typical mushroom like in shape, well-developed, and organized in peculiar
three-dimensional structures. This fully matured stage is characterized by an overall shift
in gene expression patterns that is totally different from the planktonic stages, thus,
offering an increased resistance to antimicrobials. Once they are fully developed biofilm,
via production of some biofilm destabilizing proteins like phenol soluble modulins
(psms), disassembly of biofilm occurs resulting in free-floating planktonic cells
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(dispersion) that are able to re-initiate the biofilm development process in another site
(Boles & Horswill, 2008).

Figure 1. Schematics showing biofilm development in Staphylococcus aureus.
Global Regulators that Regulates Biofilm Formation
SarA and its family of homologs are transcriptional regulators that control the
expression of several genes, including virulence factors, and biofilm formation. The sarA
locus comprises three promoters (P1, P2, and P3) that drive expression of three
transcripts (sarB, sarC, and sarA, respectively); however, the mechanism of regulation of
sarA or the significance of its three transcripts is not yet understood (Cheung & Manna,
2005). In addition, the environmental signals that modulate the expression of SarA or its
activity are not known. Inactivation of sarA leads to a reduction in biofilm formation
(Beenken et al., 2003) and to attenuation in several animal disease models (e.g., septic
arthritis (Blevins et al., 2003), osteomyelitis (Booth et al., 1997), and endocarditis (Xiong
et al., 2006)). sarA is epistatic to agr during biofilm formation (Beenken et al., 2010;
Cassat et al., 2006). SarA mutants are deficient in biofilm formation and show a reduced
expression of the icaADBC operon, increased protease and nuclease activity, degradation
of surface-associated proteins like FnbA, FnbB, and Spa (Beenken et al., 2004; Beenken
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et al., 2010; Boles & Horswill, 2008; Cassat et al., 2006; Karlsson et al., 2001; Mann et
al., 2009; McGavin et al., 1997; O'Neill et al., 2008; Tsang et al., 2008; Zielinska et al.,
2011).
Agr is also a global regulator that encodes a quorum-sensing system in S. aureus.
The agr operon produces and responds to extracellular levels of an auto-inducing peptide
(AIP) secreted by S. aureus cells. Binding of accumulated AIP initiates a regulatory
cascade that controls the expression of a myriad of virulence factors, such as proteases,
hemolysins, and toxins (Boles & Horswill, 2008; Davies et al., 1998; Novick, 2003;
Vuong et al., 2000) (Novick, R.P, 2000). The main effector molecule of agr is RNAIII,
which is expressed in temporal fashion, reaching a maximum in the transition from the
post-exponential to the stationary growth phase. The agr operon is responsible for the
repression of cell-surface proteins and the enhanced expression of secreted proteins
during stationary growth phase (Kornblum et al., 1990). Repression of agr is also
important for biofilm formation (Yarwood et al., 2004). The agr system regulates a large
number of virulence factors, especially exoprotein genes like hla, hlb, hld, hlCB, sspABC,
splABDF, aur, and many others, whereas it decreases the expression of several cell wallassociated protein genes like fnbA, fnbB, spa, and coa (Cheung et al., 1992; Janzon et al.,
1989; Mahmood & Khan, 1990; Patel et al., 1992; Recsei et al., 1986; Saravia-Otten et
al., 1997; Xiong et al., 2004).
Another important global regulator is the alternative sigma factor sigB, which
responds to environmental stress during stationary growth phases (Gertz et al., 2000;
Kullik & Giachino, 1997; Palma & Cheung, 2001; Wu et al., 1996). sigB regulates its
targets via other regulatory genes or by acting directly on the promoters of virulence
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genes. sigB positively regulates expression of sarC and negatively regulates agr, but its
effect on sarA is not yet known (Bischoff et al., 2001; Deora et al., 1997; Horsburgh et
al., 2002). It seems that sigB acts in opposition to RNAIII, as most of the exoenzymes
and toxins were negatively influenced by sigB, while the expression of several adhesins
was increased (Bischoff et al., 2004).
Current challenges in treating S. aureus Biofilm associated infections
Despite great advancement in the field of drug development, problems with
treatments of a multitude of biofilm-associated infections like endocarditis, osteomyelitis,
infections of catheters and indwelling devices, gingivitis, and deep-seated infections of
soft tissues is still a big challenge.
As mentioned above, the emergence of MRSA strains accompanied by the
evolution of Community acquired MRSA strains is currently a widespread and ongoing
challenge for the treatment of chronic infections associated with these strains (Diep et al.,
2008; King et al., 2006; Li et al., 2009; Miller et al., 2005; Morgan et al., 2007). The
ability to form biofilm by these pathogens further exacerbates the problem associated
with the treatment. Biofilms are extremely difficult to eradicate with conventional
antimicrobial agents because they offers several potential antimicrobial resistance
mechanisms (De Beer et al., 1994; Singh et al., 2010; Xu et al., 2000). Several challenges
offered by the biofilm against the therapeutic agents are:
1. Host Immune components and antimicrobials have limited activity
Biofilm formation is a very complicated process, a very well-organized
multilayered, three-dimensional mushroom shaped biofilm embedded in an
extrapolymeric matirx composed of poly-N-acetylglucosamine (PIA), extracellular DNA,
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and several heterogeneous proteins. The bacterial cells are shielded inside the slime layer
of biofilm matrix, which allows them to sequester and concentrate the environmental
nutrients and provides resistance to external antimicrobial compounds and evasion from
host clearance strategies such as phagocytes, shear stress, and host proteases by
preventing their effective penetration to show their action (Beveridge et al., 1997; Singh
et al., 2010; Xu et al., 2000).
2. Presence of diverse physiological niches within biofilm
The cells growing in biofilm include diverse population with different metabolic
states like aerobic, fermentative, dormant, and dead depending upon the location of cells.
The majority of the cells inside biofilm is dormant and resides in anoxic conditions
making them tolerant to high concentration of antimicrobials (Xu et al., 2000). Recent
studies have shown that dormant and anoxic cells within the biofilm give rise to persister
cells, which play a major role in the tolerance of biofilm bacteria to antimicrobial agents.
Persisters are not mutants but are the phenotypic variants of normal cells that achieve
dormant stage allowing them to survive the antimicrobial treatments, while they kill the
majority of their genetically identical siblings. Antibiotic tolerance or multidrug tolerance
adds an additional problem for the therapeutic purpose in the sense that very little
molecular detail is known about the persister formation. Furthermore, the physiological
pathways that lead to dormancy are redundant, thus, offering further hurdle in developing
anti-persister compounds (Beveridge et al., 1997; Conlon et al., 2013; Conlon, 2014;
Lewis, 2005; Lewis, 2010; Rani et al., 2007). Therefore, understanding the molecular
mechanisms involved in persister formation and its role in biofilm-associated
antimicrobial resistance would be the key to develop new therapeutic strategies.
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Studies have also shown the presence of small colony variants among the staphylococcus
populations, which help S. aureus, survive in a metabolically inactive state under harsh
conditions. These small colony variants are found to play important role in biofilm
formation and antibiotic resistance and have been implicated in chronic infections such as
chronic osteomyelitis (von Eiff et al., 2001).
3. Lack of consensus of the regulation of biofilm formation
Despite of a wide knowledge about so many regulators and factors involved in
biofilm development, the potential therapeutic target effective for the treatment of biofilm
associated infection is still under question because of a lack of consensus in the
regulation of biofilm development among the diverse staphylococcal strain and straindependent regulation of biofilm development. Indeed, studies have shown that
staphylococcus strains regulate biofilm formation in PIA dependent (Cerca et al., 2008;
Cramton et al., 1999; Cramton et al., 2001; Jefferson et al., 2003; Jefferson et al., 2004),
PIA independent (Fitzpatrick et al., 2005; Houston et al., 2011; Merino et al., 2009;
Toledo-Arana et al., 2005), and eDNA dependent mechanisms (Allesen-Holm et al.,
2006; Archer et al., 2011; Mann et al., 2009; Rice et al., 2003; Rice et al., 2007; Rice &
Bayles, 2008; Thomas et al., 2008).
Significance of the Study
The msa gene was initially identified as a regulator of sarA, agr, and several
virulence factors (Sambanthamoorthy et al., 2006). The author also showed that msa is
involved in biofilm development (Sambanthamoorthy et al., 2008). Indeed, the author
showed that the deletion of the msa gene resulted in a significant defect in accumulation
of biofilm but did not affect the initial adherence to surfaces (Sambanthamoorthy et al.,
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2008). However, it was not clear if msa regulated the different phenotypes directly or via
its effect on other global regulators. For instance, the study found that in the msa deletion
mutant sarA expression is reduced during biofilm growth. Since sarA has been shown to
be essential for biofilm development in several strains (Beenken et al., 2003), it is not
clear if the msa defect is due to that reduction in sarA or other factors. Sequence analysis
of the msa gene showed that it is conserved in S. aureus strains and suggested that it
encodes for a putative membrane protein (Sambanthamoorthy et al., 2006). However, the
mechanism of regulation by msa was not determined because the putative protein was
never expressed. The pleiotropic phenotypes in the msa mutant suggested that they were
mediated by the global regulators sarA, agr, and sigB. However, deletion of the msa gene
leads to a decrease in the expression of the upstream gene (cspA), a gene that is not
regulated by sarA, agr, or sigB (Nagarajan & Elasri, 2007; Sambanthamoorthy et al.,
2006). These findings led us to hypothesize that msa regulated some genes (e.g. cspA)
directly. Examination of the relationship between msa and cspA lead to the findings of
this study in which the msa (now called msaC) gene is part of a four-gene operon,
msaABCR. Furthermore, this study showed that a newly defined msaABCR operon
regulates fundamental phenotypes in S. aureus such as biofilm development and
virulence. Characterization of the msaABCR operon will allow to further investigate the
mechanism of function of this operon and the role of the individual genes in the
regulation and interaction with its targets. This study also identifies a new element in the
complex regulatory circuits in S. aureus, and the other findings that may be
therapeutically relevant.
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Perspectives to Develop New Therapeutic Strategies
for the Treatment of S. aureus Infections
Successful treatment of biofilm-associated infections is very difficult by the
classical antibiotic treatment strategies, such as antibiotic prophylaxis, aggressive, and
chronic suppressive antibiotic therapy, thus, making biofilm-associated infections
recurrent and chronic. In recent years, various concepts of anti-biofilm approaches have
been emerging by using several novel natural, synthetic, or bioengineered agents as
alternatives to classical antibiotic treatment because the modes of action of these novel
antibiofilm agents are much less susceptible to the emergence of resistance compared
with classical antibiotic treatment. In this study it has been shown that msaABCR
regulates virulence and biofilm development, so targeting msaABCR functioning in
combination with antibiotics like daptomycin and rifampicin could be the future
therapeutic for treating S. aureus biofilm associated infections.
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CHAPTER II
CHARACTERIZATION OF msaABCR OPERON
Abstract
Community-acquired, methicillin-resistant Staphylococcus aureus strains often
cause localized infections in immune-compromised hosts, but some strains show
enhanced virulence leading to severe infections even among healthy individuals with no
predisposing risk factors. The genetic basis for this enhanced virulence has yet to be
determined. S. aureus possesses a wide variety of virulence factors, the expression of
which is carefully coordinated by a variety of regulators. Previously, the msa gene as a
regulator of several virulence genes, biofilm development, and antibiotic resistance was
identified. The evidence of the involvement of upstream genes in msa function was
observed. To investigate the mechanism of regulation of the msa gene (renamed msaC),
the upstream genes whose expression was affected by its deletion was studied in detail.
This study showed that msaC is part of a newly defined four-gene operon (msaABCR), in
which msaC is a non-protein-coding RNA that is essential for the function of the operon.
Furthermore, it was found that an antisense RNA (msaR) is complementary to the 5’ end
of the msaB gene and is expressed in a growth phase-dependent manner suggesting that it
is involved in regulation of the operon. These findings allow for the definition of a new
operon that regulates fundamental phenotypes in S. aureus such as biofilm development
and virulence. Characterization of the msaABCR operon will allow investigating the
mechanism of function of this operon and the role of the individual genes in regulation
and interaction with its targets. This study identifies a new element in the complex
regulatory circuits in S. aureus, and, these findings may be therapeutically relevant.
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Introduction
Staphylococcus aureus is an important human pathogen that causes a wide range
of infections, from superficial to systemic (Novick, 2000; Tenover & Gaynes, 2000). The
ability of S. aureus to infect a variety of tissues is due to its expression of a wide variety
of virulence factors. These factors are categorized as surface-associated proteins, secreted
proteases, toxins, or immune modulators (Junecko et al., 2012). The expression of
virulence factors in S. aureus is carefully coordinated by a variety of regulators that
include trans-acting global regulators, alternative sigma factors, and small non-coding
RNAs (Felden et al., 2011; Junecko et al., 2012; Shaw et al., 2008). Indeed, the S. aureus
genome has 124 putative transcriptional regulators (Kuroda et al., 2001). Understanding
virulence regulation during growth under different environmental conditions (e.g.,
biofilm development) is imperative for the effective prevention and treatment of S.
aureus infections. To date, several global regulators have been identified, which include
the agr operon, the sarA gene family, the saePQRS operon, and the genes arlRS, lytSR,
srrAb, hssRS, vraSR, and graSR (Brunskill & Bayles, 1996; Cheung et al., 1992; Cheung
et al., 2008; Falord et al., 2011; Fournier & Hooper, 2000; Gardete et al., 2006; Giraudo
et al., 1994; Peng et al., 1988; Torres et al., 2007; Yarwood et al., 2001). Several other
regulators have also been identified, though they are not well characterized (e.g., htrA,
ccpA, msrR, and svrR) (Mei et al., 1997; Moskovitz et al., 2002; Rigoulay et al., 2005;
Seidl et al., 2006).
The msa gene, henceforth referred to as msaC, was initially identified as a
regulator of sarA, agr, and several virulence factors (Sambanthamoorthy et al., 2006).
Previously it was reported that msaC is involved in biofilm development and virulence
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(Sambanthamoorthy et al., 2008). Indeed, the deletion of the msaC gene resulted in a
significant defect in accumulation of biofilm but did not affect the initial adherence to
surfaces (Sambanthamoorthy et al., 2008). However, it was not clear if msaC regulated
virulence genes directly or via its effect on global regulators. For instance, The study
showed that in the msa deletion mutant, sarA expression was reduced during biofilm
growth. Since sarA has been shown to be essential for biofilm development in several
strains (Beenken et al., 2003), it is not clear if the msaC defect is due to the reduction in
sarA or other factors. A sequence analysis of the msaC gene showed that it is conserved
among S. aureus strains and suggested that it encodes a putative membrane protein
(Sambanthamoorthy et al., 2006). However, this putative protein was never expressed;
therefore, the mechanism of regulation by msaC remains to be determined. The
pleiotropic phenotypes in the msaC mutant suggested that they were mediated by the
global regulators sarA, agr, and sigB. However, the deletion of the msaC gene leads to a
decrease in the expression of the upstream gene (cspA), a gene that is not regulated by
sarA, agr, or sigB (Nagarajan & Elasri, 2007; Sambanthamoorthy et al., 2006). These
findings led to hypothesize that msaC regulated some genes (e.g., cspA) directly. This
study further examined the relationship between msaC and cspA and showed that the
msaC gene is part of a four-gene operon.
Materials and Methods
Bacterial strains and plasmids
Staphylococcus aureus strains (community-acquired MRSA strain
USA300_LAC, restriction-deficient laboratory strain RN4220) and E. coli strain DH5α
were used in this study. S. aureus strains were grown in a tryptic soy broth (TSB)

16
medium. Antibiotics (chloramphenicol (10 μg/ml), erythromycin (10 μg/ml), and
kanamycin (50 μg/ml) were used in TSB or TSA where needed. Similarly, E. coli strains
were grown in LB broth with ampicillin (100 μg/ml) added where needed. Detailed
information about the strains and plasmid constructs used in this study is listed in
Supplemental Table S2.1.
RNA isolation and real-time qPCR
Total RNA for the SmarterTM rapid amplification of cDNA ends (RACE) reaction
was isolated from cells using a Qiagen RNeasy Maxi column (Qiagen, Valencia CA), as
previously described in Sambanthamoorthy et al. (Sambanthamoorthy et al., 2006).
Briefly, overnight cultures of S. aureus were diluted to an OD600 of 0.05 in TSB and
incubated at 37 °C with shaking (200 rpm) until they reached an OD600 of 1.5. The quality
of total RNA was determined by Nanodrop spectrometer readings, as well as using a
Bioanalyzer (Agilent). For real-time quantitative PCR (RT-qPCR) of the transcript, the
total RNA was isolated from three different growth phases (early exponential, midexponential, and late-exponential), and RT-qPCR was performed as described previously
(Sambanthamoorthy et al., 2006). The constitutively expressed gyrase A (gyrA) gene was
used as an endogenous control gene and was included in all experiments. Analysis of
expression of each gene was done based on at least three independent experiments. Twofold or higher changes in gene expression were considered significant. All of the primers
used for RT-qPCR are listed in Table 2.4.
Analysis of mRNA transcripts by Rapid Amplification of cDNA Ends (RACE) Reactions
Analysis of msa mRNA transcript was carried out using the SMARTERTM RACE
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cDNA Amplification Kit as instructed in the user manual. The locations and sequences of
gene-specific primers used for 3’ and 5’ RACE are shown in Figure 2 and Table S2.2.
The 5’ RACE cDNA amplification was carried out using the random primer mix
(N-15) provided in the kit. Alternatively, for confirmatory purposes, the 5’ RACE cDNA
amplification was also performed using the poly (A)-tailed total RNA after the poly (A)
polymerization of the total RNA. The 5’ RACE Ready-to-use cDNA was diluted to 100
l and stored at –20 °C until use. RACE was performed using universal primer mix, 5’
RACE primers, and the Advantage 2 Polymerase mix. Control experiments and all of the
optimizations for the RACE reactions were performed as instructed in the manual.
RACE-amplified product (5 µl) was resolved in a 1.2% gel to visualize the bands. The
RACE products were gel purified and sequenced. The resulting sequence was used in a
BLAST search on the NCBI website, and the 5’ end of the mRNA sequence was
determined.
For the 3’ RACE reaction, the poly (A) tail was first added to the total RNA using
the Poly (A) Polymerase kit. The 3’-RACE cDNA amplification was performed with 3’
SMART CDS Primer A provided in the kit. The 3’-RACE-Ready cDNA was diluted up
to 100 µl and stored at –20 °C until use. RACE was performed using an universal primer
mix, 3’ RACE primers, and the Advantage 2 Polymerase mix. As above, control
experiments and optimizations were performed, and the RACE products were visualized,
gel purified, and sequenced. The resulting sequence was used in a BLAST search to
determine the 3’ end of the mRNA sequence.
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Northern blot analysis
Total RNA for Northern blotting was harvested as described above. Cells were
harvested at optical densities (A600) of 0.7, 1.5, and 4.0, which correspond to earlyexponential, mid-exponential, and late-exponential, growth phases, respectively.
Northern blots were performed using the DIG Northern starter kit, according to the
manufacturer’s instructions (Roche Biochemicals, Mannheim, Germany). DIG-labeled
riboprobes [200–300 bp] for msaA, msaB, msaC, and msaR were generated by
transcription using the kit. The blotted membrane was prehybridized in 25 ml of DigEasy-Hyb buffer for 2 h at 50 °C with rotation and hybridized in the same Dig-Easy-Hyb
buffer containing 25 ng/ml DIG-labeled riboprobes overnight at 42 °C. The hybridized
membrane was first washed twice with 2× SSC and 0.1% SDS for 30 min at 37 °C,
followed by two 0.5× SSC and 0.1% SDS washes for 30 min at 50 °C with rotation. After
washing with 1× wash buffer (Roche) for 5 min, the membrane was incubated with
blocking solution for 60 min and antibody solution (anti-DIG-alkaline phosphatase, 75
mU/ml) for 60 min at 37 °C with rotation. The membrane was then equilibrated with 100
ml of detection buffer for 2–5 min and covered with 1 ml of the chemiluminescent
substrate CDP-Star (Roche) for 10 min at room temperature, according to the
manufacturer’s protocol. The membrane was immediately exposed to film for 3–30 min.
Construction of promoter–LuxAB fusions and luciferase assays
The E. coli–staphylococcal shuttle vector pCN58, which contains the low-copynumber staphylococcal replicon cassette (pT181copwt repC) and a promoterless reporter
gene, luxAB (encoding the luciferase from Vibrio ficheri) for transcriptional fusions
(Charpentier et al., 2004), was used for the study of the promoter activity of the
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individual ORFs (msaA, msaB, msaC, and msaR). The upstream 200–300-bp regions
from individual genes were PCR amplified and cloned into the pCN58 vector. The
recombinant vectors were first transformed into RN4220, followed by transduction into
the USA300 LAC strains. To study the promoter–luciferase activity, overnight bacterial
cultures were diluted 1:10 in TSB and further incubated for 3 h. Cells were then
normalized to OD 0.05 and further incubated at 37 °C with shaking (220 rpm). Bacterial
cells (5 ml) were harvested at different optical densities (OD600 of 0.7, 1.5, and 4.0)
representing early-exponential, mid- and late-exponential stages, respectively. The cells
were washed once with 1× PBS and resuspended in 500 μl of 1× PBS. The cell
suspension (500 μl) was mixed with 100 μl of 1% decanal (v/v) in 90% ethanol, and
luminescence was measured immediately after mixing using a luminometer, based on a
10-s measurement in the integrated data mode. Luciferase activity was recorded as
relative luminescence units (RLUs), and the specific luciferase activities were calculated
by dividing the RLU values by the absorbance of the organism (RLU/OD600). The
promoterless version of the reporter gene plasmid (pCN58) was used as a control in
reporter gene assays.
Deletion of the msaABCR operon in the USA300 strain LAC and complementation
This study used a previously described mutagenesis protocol to construct a
nonpolar, in-frame deletion of the msaABCR operon in the S. aureus USA300 strain LAC
(Bae & Schneewind, 2006). Briefly, the flanking regions (~1 kb) of the msaABCR operon
were amplified by PCR and ligated together at an introduced BamHI restriction site. This
PCR product was inserted into the temperature-sensitive plasmid pKOR1 using the
Gateway BP Clonase Enzyme Mix (Invitrogen Inc.). The pKOR1–msa operon deletion
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construct was introduced into S. aureus USA300 strain LAC. The culture was grown in
TSB in the presence of chloramphenicol (10 μg/ml) at the permissive temperature of 30
°C. Cells were plated on TSA containing chloramphenicol at 43 °C, a non-permissive
temperature for pKOR1 replication. Colonies were picked and allowed to grow in TSB at
the permissive temperature and then plated on a TSA containing 100 ng/ml of
anhydrotetracycline, which induces antisense secY RNA expression and promotes the
loss of plasmid. Two rounds of temperature shifts were necessary to isolate the deletion
mutant. Deletion of msaABCR in LAC was verified by end-point and real-time PCR, and
functional assays were performed as described previously [21]. To complement the
msaABCR deletion mutation, a 1788-bp fragment of the msaABCR operon gene with
complete 5’ and 3’ untranslated regions was amplified and ligated to pCN34 (NARSA), a
low-copy-number, Gram-positive shuttle vector. The complement plasmid construct was
introduced into strain RN4220 by electrophoresis and then transduced into the msaABCR
deletion mutant. The msaABCR operon gene in the complemented strain was under the
control of its native promoter. The agr operon of the msa mutant was sequenced and
compared it with the parent strain to ensure that it had not spontaneously mutated during
construction of the msa operon deletion mutant.
Mutagenesis study
Overlap extension PCR cloning technique was used to generate a frame shift
mutation in the msaC ORF as described by Bryksin et al. (Bryksin & Matsumura, 2010).
The upper 1120-bp fragment of the msaABCR operon was PCR amplified using the
primer set fsmut-msa F1 and fsmut-msa R1, and the lower 650-bp fragment of the
msaABCR operon region was amplified using the primer set fsmut-msa F2 and fsmut-msa
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R2. Primers fsmut-msa R1 and fsmut-msa F2 overlap such that a deletion of one
nucleotide was introduced causing a frameshift mutation in msaC. Both of the PCR
fragments were PCR purified using the Promega DNA cleanup kit, and then 50 ng of
each of the fragments were used in the PCR ligation, which contained all of the
components of the PCR mix except the terminal primers. The normal PCR cycle was
carried out for 15 cycles. Then, the terminal primers (fsmut-msa F1 and fsmut-msa R2)
were added to the reaction, and a 20 additional cycles were performed. The final
amplified PCR product was ligated to the pCN34 low copy number plasmid vector and
transduced into the msaABCR operon deletion mutant.
Pigmentation assay
A pigmentation assay was performed on cells harvested from overnight cultures,
as described by Morikawa et al. (Morikawa et al., 2001). Briefly, 1 ml of the cells were
harvested and washed twice with water. They were then suspended in 1 ml of methanol
and heated at 55 °C for 3–5 min with occasional vortexing. The cells were removed by
centrifugation at 15,000 x g for 1 min, and the absorbance of the supernatant was
measured at 465 nm with water as a blank. Mean values from a minimum of three
independent experiments, each performed in triplicate, were recorded.
Protease assay
Protease activity was measured from the supernatants of 4-h and overnight
cultures as described by Sambanthamoorthy et al. (Sambanthamoorthy et al., 2006).
Briefly, 300 μl of the culture supernatant was mixed with 800 μl of 3 mg azocasein
ml−1 in Tris-buffered saline (pH 7.5) and incubated overnight at 37 °C. Undegraded
azocasein was precipitated by adding 400 μl of 50% (w/v) trichloroacetic acid, removed
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by centrifugation, and the remaining acid-soluble azocasein was quantified by
measuring the absorbance at A340. Mean values from a minimum of three independent
experiments, each performed in triplicate, were recorded.
Biofilm assays
The microtiter biofilm assay was performed as described in Sambanthamoorthy et
al. (Sambanthamoorthy et al., 2008) with slight modification. In brief, overnight cultures
of cells, including wild type, mutant, and the complemented strain of USA300 LAC were
diluted 1:100 times in TSB supplemented with 3% NaCl and 0.25% glucose and
inoculated in microtiter plates pre-coated with 20% human plasma. Cultures were
incubated for 24 or 48 h with shaking at 150 rpm. The adherent biofilm was quantitated
at 615 nm after washing and staining with crystal violet and elution with 5% acetic acid.
Mean values from a minimum of three independent experiments, each performed in
triplicate, were recorded.
Results
msa is a member of a four-gene operon
Previously, it was shown that msaC regulates the expression of sarA, and is
essential for biofilm formation and protease production (Sambanthamoorthy et al., 2006;
Sambanthamoorthy et al., 2008). One of the early observations about msaC was that the
expression of the upstream gene (SAUSA300_1295) was significantly reduced (two-fold)
by the deletion of msaC (Sambanthamoorthy et al., 2006). In addition, some assays
involving the expression of upstream genes did not show full complementation when the
msaC gene alone was introduced into the msaC mutant. To investigate this further, the
msaC gene was deleted from the S. aureus community-acquired strain, USA300 LAC,
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and complemented the mutant with a region of the chromosome that included upstream
and downstream genes relative to msaC. The introduction of three open reading frames
(ORFs) (encoding SAUSA300_1296, SAUSA300_1295, and msaC) resulted in full
complementation to restore the wild type phenotype in biofilm formation, host protein
binding assays, protease production, and expression of sarA. These findings suggested
that the msaC gene is part of an operon that included at least three genes. To test this
hypothesis, all three genes (encoding SAUSA300_1296, encoding SAUSA300_1295, and
msaC) were deleted in the USA300 LAC strain and compared the phenotype to the msaC
single-deletion mutant. Several phenotypic variables were examined in the two mutants,
and similar phenotypes were observed, as they were both defective in pigmentation,
protease production, biofilm development (Figure 2.1), and expression of the key global
regulators, sarA, agrA, and sigB (Table 2.1). The phenotype of the three-ORF-deletion
mutant was similar to the msaC mutant, with one exception being that the three-ORFdeletion mutant produced significantly more proteases than the msaC mutant (Figure 1B).
Furthermore, complementation studies in the msaC deletion mutant confirmed that all
three ORFs were required for the restoration of the wild type phenotype (Figure 1, Table
1). These findings suggested that the three genes are functionally related and form an
operon.

24

25

Figure 2.1. Phenotypic analysis of the msaC and msaABCR deletion mutants and
complements. Comparison of the msaC and msaABCR deletion mutants phenotypes
relative to complemented mutants and wild type USA300LAC. Phenotypic assays were
done on (A) pigmentation; (B) production of extracellular proteases; and (C) Biofilm
formation. Values are shown as the percent activity relative to wild type strain USA300
LAC which was set as 100%. Values represent the average of three independent assays
which were done in triplicates. Results are reported as the mean ± S.E.
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Table 2.1
Relative expression of the global regulators; sarA, agr and sigB in the msaC and
msaABCR deletion mutants.
Fold change
Strain

sarA

agrA

sigB

LAC
Δ msaC
Δ msaC + pMOE402 (msaC)
Δ msaC + pMOE403 (msaABCR)
Δ msaABCR
Δ msaABCR + pMOE403 (msaABCR)

1
-3.03
-3.45
-1.74
-3.59
-1.39

1
-5.72
-6.74
1.74
-6.7
-1.56

1
-2.37
-2.23
-1.35
-2.07
1.01

Note: Fold change transcription level in the various strains relative to wild-type (USA300 LAC). Values represent the mean ratio for
at least three independent experiments.

The transcripts produced by these three ORFs were analyzed by using rapid
amplification of cDNA ends (RACE) and Northern blot analyses. The SMARTerTM
RACE cDNA Amplification kit (Clontech) was used to analyze the mRNA transcripts
harvested from the USA300 LAC strain. Several gene-specific primers were used to find
the 5’ and 3’ ends of all transcripts produced by this operon. The RACE reaction products
were separated by agarose gel electrophoresis, and the different DNA bands observed
were gel purified and sequenced. The results from RACE analysis (5’ and 3’) showed the
production of a 1541-nt RNA whose 5’ end was located 35 nt upstream of the gene
encoding SAUSA300_1296 (renamed msaA), while its 3’ end was located 230 nt
downstream of the gene encoding SAUSA300_1294 (msaC). The ends of each transcript
were confirmed using at least two different primers and three independent reactions for
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each primer (Figure 2.2). Results of the RACE analysis were confirmed by Northern blot
analyses using gene-specific probes (Figure 2.3).

Figure 2.2. Map of the msaABCR operon. Rapid Amplification of cDNA ends (RACE)
and Northern blot analyses were used to determine the length and ends (5’ and 3’) of the
RNA transcripts produced by the msaABCR operon. Short thick arrows indicate the
positions and directions of the gene-specific primers used in the separate reactions. Long
thin arrows represent the various RNAs identified in this study with indication of
direction and length in nucleotides (nt). Reporter gene fusions studies showed the
presence of only one active promoter (P) in this operon.
The findings from RACE and Northern analyses confirmed that msaC is part of a
three-gene operon that comprises a gene that encodes for a hypothetical protein
(SAUSA300_1296), a gene that is similar to the E. coli cold-shock gene (cspA, encoding
SAUSA300_1295) and the msaC gene (encoding SAUSA300_1294) (Figures 2.2 and
2.3). This indicated that all three genes were functionally related and involved in biofilm
development, protease production, and regulation of the sarA, agr, and sigB genes. This
operon was renamed as msaABCR, where msaA encodes SAUSA300_1296, msaB
encodes SAUSA300_1295, msaC encodes SAUSA_1294 (originally named msa), and
msaR codes for an anti-sense RNA (see below).
Another interesting finding from RACE and Northern blot analyses was that in
addition to the large transcript, there were three sub-transcripts corresponding to msaAB,
msaB, and msaC (Figures 2.2 and 2.3). Additionally, Northern blot analyses using an
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msaA-specific riboprobe showed the presence of a transcript that corresponded to msaA
alone; however, the ends of this transcript was not detected by RACE (Figure 3).
Northern blot analysis also revealed that msaB was the most abundant transcript produced
from this operon, whereas the large msaABC transcript and the msaC transcript were
present at a much lower level (Figure 2.3). The expression level of these transcripts was
further confirmed by real-time quantitative PCR (RT-qPCR) (Figure 2.4). These results
suggested that the large transcript may be processed resulting in the production of the
msaB transcript.

Figure 2.3. Transcription of the msaABCR operon. Northern blots were used to detect the
different transcripts produced by the msaABCR operon at three growth phases (early
exponential, mid exponential, and late exponential). Gene specific ribo-probes were used
to identify the transcripts produced by this operon as indicated on the left. Size marker
(nt) is shown on the left next to ribo-probes label.
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Figure 2.4. Absolute quantification of individual of ORFs in the msaABCR operon. Realtime quantitative PCR was used to compare the expression level of three genes in the
msaABCR operon in three growth phases. These results confirm findings from Northern
blot analyses showing that despite co-expression the msaB transcript is the most
abundant. Results were obtained from three independent experiments. Values represented
the mean ± S.E.
The msa operon contains an anti-sense RNA (msaR)
Sense riboprobe that hybridizes to the msaB region was also used to performed
northern blot analysis. The probe detected an anti-sense RNA that partially overlaps with
the msaB transcript. RACE analysis was performed to identify the ends of the anti-sense
RNA and found that it is 133 nt in length and is complementary to 112 nt of the 5’ UTR
region of msaB and 18 nt of the msaB ORF region (Figure 2.2). The results are also
supported by the identification of this anti-sense RNA in a screen of endoribonuclease III
targets in the S. aureus strain RN6390 (Lioliou et al., 2012). Lioliou et al. (Lioliou et al.,
2012) found that this 133-nt RNA is involved in regulating the stability of the cspA
(msaB) mRNA. To investigate this further, the expression level of this anti-sense
transcript was measured at three growth phases and found that it was produced at earlyexponential and mid-exponential phases, but it was absent at late-exponential phase
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(Figure 2.3). The absence of the anti-sense transcript in the late-exponential growth phase
may be due to the lack of production or degradation. This differential expression may
play an important role in the activity of the operon and indicates that regulation of the
operon by msaR is growth-phase dependent.
Detectable promoter activity within the operon is limited to msaA
RACE and Northern blot analyses showed that, in addition to the large transcript
(msaABC), the operon produces four sub-transcripts (msaAB, msaB, msaC, and msaR).
These transcripts might be produced from individual promoters or via processing of the
large transcript. To test this, the putative promoters from all of the genes in the operon
were fused to a promoterless luciferase gene, luxAB. Two promoter-prediction software
packages, PePPER (prediction of prokaryote promoter elements and regulon) (de Jong et
al., 2012) and Virtual footprint (promoter analysis version 3.0) (Munch et al., 2005),
were used to select the putative promoters. The promoters included 250 to 300 bp of
sequence upstream of each ORF. Selection of the putative promoter regions was also
based on the results of RACE analysis by considering every detected 5’ end as a possible
transcription start point. The fusions were also introduced into the wild type strain and
assayed for light production in three growth phases (early-exponential, mid-exponential,
and late-exponential). The study showed that under these growth conditions, the msaA
promoter was active in all three-growth phases. However, the putative promoters for
msaB and msaC did not show any detectable light production (Figure 2.5). These findings
further confirmed that a single promoter drives expression of the genes in the msaABC
operon and that the sub-transcripts probably arise from the processing of the main
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transcript. However, the function of the other putative promoters cannot be ruled out
completely, which may be active under growth conditions that have not yet being tested.

Figure 2.5. Promoter activity in the msaABCR operon at three growth phases. Putative
promoters were fused to promoter-less luxAB genes and introduced into the wild type
strain USA300 LAC. Luciferease activity was measured at three growth phases (early,
mid and late exponential). The vector pCN58 containing luxAB without a promoter was
used as a negative control. Results represent the means of three independent experiments
where each measurement was done in triplicates. Standard error bars are shown.
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Figure 2.6. Activity of the msaABCR promoter. Activity of the primary promoter was
measured in the msaC and msaABCR deletion mutants. Luciferease activity was
measured at three planktonic growth phases (early, mid and late exponential) and biofilm.
The vector pCN58 containing luxAB without a promoter was used as a negative control
(not shown). Results represent the means of three independent experiments where each
measurement was done in triplicates. Standard error bars are shown.
To further examine the potential role of the msaA promoter in the regulation of
expression of the operon, msaA–luxAB fusions were introduced into the two deletion
mutants, the msaABCR operon, and msaC. The result showed that the promoter activity
was significantly increased (>2 fold) in both mutants, indicating a negative autoregulation mechanism that controls the expression of the operon (Figure 2.5B).
Interestingly, this increase in expression was observed in three phases of planktonic
growth as well as in biofilms.
msaC is a non-protein-coding RNA
Studies on the msaC gene were initiated by the discovery of its role in the
expression of sarA and several virulence factors. This study showed that msaC is part of a
four-gene operon, msaABCR, and that its deletion leads to a phenotype that is equivalent
to deletion of the whole operon. The lack of similarity of the predicted protein sequence
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encoded by msaC with protein databases and failure to express the protein using several
approaches led to the hypothesis that msaC is a non-coding RNA. The mutant was
constructed in the msaABCR operon that contained a frameshift mutation in the msaC
ORF that did not significantly change the predicted secondary structure of the RNA
(Figure 2.6 A and B). This frame shift mutation led to the introduction of several
nonsense mutations in the putative msaC ORF (Figure 2.6 C and D).

Figure 2.7. Predicted structure of msaC RNA and its putative protein sequence.
Frameshift mutation (deletion of one U) was introduced into the msaC gene of msaABCR
operon. msaC RNA in wild type (a) and frameshift mutant (b) shows no significant
difference in secondary structure. Putative protein sequence of wild type (c) and the
mutant (d), which shows the introduction of several stop codons.
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The mutated operon (msaABCR_fsmut msaC) was introduced into the msaABCR
deletion mutant. The phenotype of this strain was compared to the wild type strain and to
the msaABCR deletion mutant complemented with wild type msaABCR. The results
showed that the frameshift mutant operon (msaABCR_fsmut msaC) complemented the
deletion mutant in pigmentation, protease production, biofilm development, and
expression of three global regulators sarA, agrA, and sigB (Figure 2.7, Table 2.2). The
level of complementation between the msaABCR operon and msaABCR-fsmut-msaC did
not show a statistically significant difference (Figure 2.7 and Table 2.2). These results
suggested that the msaC gene does not encode a protein. The absence of the MsaC
protein from all current proteomic studies in S. aureus further supported the conclusion
that msaC produces a non-protein-coding RNA that is required for the expression of the
msaABCR operon (Cordwell et al., 2002; Ning et al., 2013).
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Figure 2.8. Phenotypic analysis of the msaABCR deletion mutant complemented with the
the frameshift msaC mutation. The msaABCR operon construct containing the frameshift
msaC mutant was introduced in the msaABCR operon deletion mutant. Phenotypic assays
were done on (A) pigmentation; (B) production of extracellular proteases; and (C)
Biofilm formation. Values are shown as the percent activity relative to wild type strain
USA300 LAC that was set as 100%. Values represent the average of three independent
assays, which were done in triplicates. Results are reported as the mean ± S.E.
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Table 2.2
Relative expression of the global regulators, sarA, agr, and sigB in the msaABCR
deletion mutant complemented with the frameshift msaC mutation.
Fold change
Strain
LAC
Δ msaABCR
Δ msaABCR + pMOE555 (msaABCR_fsmut msaC)
Δ msaABCR + pMOE403 (msaABCR)

sarA
1
-3.59
-1.25
-1.39

agrA
1
-6.7
-1.04
-1.56

sigB
1
-2.07
-1.08
1.01

msaC
1
0
17.95
16.37

Note: Fold change transcription level in the various strains relative to wild-type (USA300 LAC). Values represent the mean ratio for
at least three independent experiments.

Discussion
Mutation of the msaC gene was shown to have a pleiotropic effect on the
expression of a variety of genes that are involved in virulence, biofilm development, and
pigmentation (Sambanthamoorthy et al., 2006; Sambanthamoorthy et al., 2008). This
study showed that the msaC gene is part of a four-gene operon that includes two putative
RNA regulators (msaC and msaR). This study also showed that msaABCR interacts with
three global regulators sarA, agr, and sigB. The location of the msaC gene in an operon is
a significant finding because it has allowed for the identification of other genes that are
functionally related, and it will facilitate the study of the mechanism of regulation by this
operon.
Sequence analysis of the genes in the msaABCR operon showed that the putative
protein produced by msaA is a conserved hypothetical protein in S. aureus. The I-Tasser
program was used to predict the protein structure and function of the putative MsaA
protein and found that it has strong similarity to the twin-arginine signal-binding protein.
In many bacterial systems, twin-arginine transport is used for translocation of folded
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proteins across the cytoplasmic membrane (Biswas et al., 2009). In S. aureus, however,
no such system has been described in detail. Analysis of the predicted MsaA structure
also revealed that it is likely located in the cytoplasm and that it might be involved in the
regulation of small GTPase-mediated signal transduction (Roy et al., 2010; Zhang, 2008).
The contribution of the putative MsaA protein to the function of the operon remains
unclear.
The msaB gene encodes a 66-amino acid polypeptide that showed homology with
cold-shock proteins of E. coli (CspA, 60%) and Bacillus subtilis (CspB, 76%). Based on
sequence homology, S. aureus produces three proteins (CspA, CspB, and CspC) that may
be associated with cold-shock stress (Chanda et al., 2010; Katzif et al., 2003; Katzif et
al., 2005). However, Anderson et al. (Anderson et al., 2006) showed that only CspB
responds to cold shock in S. aureus. This was confirmed by proteomic studies that
showed an increased expression of CspB under cold shock while CspA was not
differentially expressed. Studies have also shown that the cspA transcript is more
abundant than cspB and cspC under normal growth conditions at 37 °C, while the cspB
transcript predominates at 15 °C (Anderson et al., 2006). In addition, Katzif et al. (Katzif
et al., 2003; Katzif et al., 2005) showed that cspA is important for the cationic
antimicrobial peptide of human lysosomal cathepsin G and regulates the pigmentation in
S. aureus through a sigB-dependent mechanism (Katzif et al., 2003; Katzif et al., 2005).
This indicates that CspA has biological functions other than the cold-shock response.
These findings support this conclusion as this study have shown that msaB (CspA) acts as
a regulator of several genes that are involved in protease production, virulence, and
biofilm development. At this point, it is not clear how this protein interacts with other
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factors, but the identification of the msaABCR operon will allow to investigate this
mechanism and further characterize this new regulator of virulence.
In E. coli, the cspA mRNA is a thermosensor that modulates the translation of the
cold-shock protein (CspA). The cspA mRNA in E. coli undergoes post-transcriptional
modification in response to environmental variations such as a temperature shift from 37°
C to 10 °C (Brandi et al., 1996; Giuliodori et al., 2010). This RNA-dependent regulation
of gene expression allows E. coli to rapidly adapt and respond to its environment. Further
studies have shown that the cspA gene in E. coli produces a single-stranded nucleic acidbinding protein and an RNA chaperone. This protein is one of the most abundant proteins
during early growth phase, and its expression is even higher during cold shock,
accounting for 2% of the total proteins in the cell (Goldstein et al., 1990; Jiang et al.,
1997; La Teana et al., 1991). Since MsaB (CspA) is not directly involved in cold shock
in S. aureus, it is not clear if it has maintained the same mechanism of regulation or
functions as its homolog in E. coli. Based on these findings and those of Lioliou et al.
(Lioliou et al., 2012), the MsaB transcript in S. aureus binds the anti-sense RNA (msaR),
which contributes to its expression. msaR is detectable in the early and mid-exponential
growth phases but not in the late exponential phase. The msaB transcript, however, is still
present in late exponential growth phase albeit at a slightly lower level. It is not known at
this point how this correlates with the production of the MsaB protein and what the
significance of the differential expression of msaR is. It is also not known if the decrease
in msaR in late exponential growth phase is due to increased degradation of the anti-sense
RNA or lack of production of the transcript. Lioliou et al. (Lioliou et al., 2012) have
shown that anti-sense RNA (msaR) binds to the 5’ UTR region of a long transcript of
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cspA (msaB) and prevents its processing by RNaseIII into a shorter transcript. The short
transcript is presumably more stable than the long one and is translated more efficiently
to produce the CspA (MsaB) protein. This processing might also be responsible for the
abundance of the msaB transcript and suggests that it is the main product of the
msaABCR operon. This also suggests that MsaB may be the main effector responsible for
the functions that have been shown in this study such as biofilm development and
regulation of virulence genes (Sambanthamoorthy et al., 2006; Sambanthamoorthy et al.,
2008).
These findings suggest that msaC produces a non-coding RNA. These findings
are supported by the absence of an MsaC protein from all proteomics studies in S. aureus.
MsaC RNA is expressed in the 3’ end of the msaB transcript, and its deletion leads to a
significant reduction in msaB transcript (Sambanthamoorthy et al., 2006) and mutant
phenotypes that are similar to the deletion of the whole operon msaABCR. This suggests
that msaC plays a regulatory role in the expression of MsaB. Interestingly, msaC is found
both as an independent transcript and part of the large operon transcript (Figure 2.2). The
msaC promoter activity was not detected under the conditions tested, which suggested
that the smaller msaC transcript was the result of, processing of the large operon
transcript. The mechanism by which msaC regulates the expression of msaB is not clear
and requires further studies.
The identification of the msaABCR operon will add insight into the complex
network of virulence regulation in S. aureus. Despite the identification of numerous
regulatory elements in S. aureus, it is still not clear how this organism achieves the
coordinated expression of virulence factors in the host. Additionally, the strain-dependent
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differences observed in the pattern of regulation of virulence in S. aureus complicate this
problem further (Junecko et al., 2012). Therefore, the addition of the msaABCR operon to
the known repertoire of regulators used by S. aureus and studying its interactions with
other regulators will improve the understanding of staphylococcal biology and the
infectious process. This study was performed using a representative strain of the USA300
clonal lineage, whose hallmark phenotype is the high production of toxins, proteases, and
phenol-soluble modulins (Joo et al., 2011; Tenover & Goering, 2009). It has been
suggested that the unique regulation pattern of toxins in these stains is primarily
responsible for their increased virulence and epidemic spread. The msaABCR operon
positively regulates the agr operon and therefore may play an important role in the
phenotype of this epidemic lineage of S. aureus. The contribution of the msaABCR
operon to the fine-tuning of virulence expression via agr and other regulators is still an
undergoing investigation.
Conclusion
In this study, a new operon, msaABCR, was identified which regulates virulence
and biofilm development in S. aureus. Two RNAs, msaC and msaR, regulate expression
of this operon. The msaC gene was shown to be essential for the expression and function
of the operon since its deletion resulted in a similar phenotype to deletion of the whole
operon. These findings indicated that the main transcript produced by the operon was
msaB, which encodes the effector protein. The pleiotropic effects observed by the
deletion of the msaABCR operon are probably mediated by its interactions with the global
regulators sarA, agr, and sigB. Studies are underway to define the mechanism of
regulation of the msaABCR operon and how it interacts with its target genes.
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Table 2.3
Strains and plasmids used in this study
Plasmid

Relevant Characteristics

Source

pKOR1

E. coli-S. aureus shuttle vector, ori(Ts)
inducible, secY antisense counterselection,
Ampr Cmr
pKOR1: Δ msa operon deletion construct
pT181-based low copy number E. coliStaphylococcal shuttle vector
pCN34-msaC gene :: msaC gene complement
pCN34-msaABCR operon :: msaABCR operon
complement
pT181-based E.coli-staphylococcal shuttle vector
that contains promoterless LuxAB as a reporter
gene for promoter-gene fusion.
pCN58-Promoter msaA
pCN58-Promoter msaB
pCN58-Promoter msaC
pCN58-Promoter msaR
pCN58-Promoter sarAP1
pCN34-msaABCR_fsmut msaC

Dr. Taeok Bae

Restriction deficient mutant of 8325-4
CA-MRSA USA300 strains
LAC :: Δ msaC deletion mutant
LAC :: Δ msaABCR operon deletion mutant
MOE 383 :: pMOE 402 :: msaC gene complement
into msaC deletion mutant
MOE 383 :: pMOE 403 :: msaABCR complement
into msaC deletion mutant
MOE 401 :: pMOE 403 :: msaABCR complement
into msaABCR deletion mutant
MOE 401 :: pMOE 555 :: msaABCR_Fsmut msaC
complement into msaABCR deletion mutant
MOE 383/pCN34-vector control
MOE 401/pCN34-vector control
LAC :: pCN58-Promoter msaA
LAC :: pCN58-Promoter msaB
LAC :: pCN58-Promoter msaC
MOE 383/ pCN58-Promoter msaA
MOE 383/ pCN58-Promoter msaB
MOE 383/ pCN58-Promoter msaC
MOE 401/ pCN58-Promoter msaA

NARSA
Dr. Lindsey Shaw
This study
This study
This study

pMOE 399
pCN34
pMOE 402
pMOE 403
pCN58

pMOE 481
pMOE 482
pMOE 483
pMOE 498
pMOE 501
pMOE 555
Strain
RN4220
LAC
MOE 383
MOE 401
MOE 392
MOE 393
MOE 404
MOE 555
MOE 413
MOE 414
MOE 481
MOE 482
MOE 483
MOE 484
MOE 485
MOE 486
MOE 487

This study
NARSA
This study
This study
NARSA

This study
This study
This study
This study
This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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Table 2.3 (continued).
Strain

Relevant characteristics

Source

MOE 488
MOE 489
MOE 495
MOE 496
MOE 497
MOE 498
MOE 499
MOE 500
MOE 501
MOE 502
MOE 503

MOE 401/ pCN58-Promoter msaB
MOE 401/ pCN58-Promoter msaC
LAC :: pCN58-vector control
MOE 383/ pCN58 vector control
MOE 401/ pCN58 vector control
MOE / pCN58-Promoter msaR
MOE 383/ pCN58-Promoter msaR
MOE 401/ pCN58-Promoter msaR
MOE /pCN58-Promoter sarAP1
MOE 383/pCN58-Promoter sarAP1
MOE 401/pCN58-Promoter sarAP1

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Table 2.4
Primers used in this study
Primers used in RACE reactions
5 RACE msaC
5 RACE msaC 1
3 RACE msaC
5 RACE msaB
3 RACE msaB
5 RACE msaA
3 RACE msaA
5 RACE msaR
3 RACE msaR

CCCAGAAATCATTATCGGAATCACTAATACAATCA
TACCACACTTTAAACAAGCATCATGAAATTAG
TAGTTGCTAATTTATTAGTTTTCGGTGTATTAT
TATAGTTTAACAACGTTTGCAGCTTGTGGAC
ACGCTGAAAAAGGATTCGGCTTTATCGAAGTTGAA
ATAAAATATTTGTAAATCCTCTTCACAATCTTCG
CAGTTACCAAAATTAGAGCCGATTATGAGGGATGG
AGCAGATGATTATTCCATATTGCAAAGAATATTTGAGTGA
ACTGTACCTTGTTTCATAATCTGAAACCTCCAAGACTA

Primers used in Northern blot analysis
NB msaC R
TAATACGACTCACTATAGGGCAACAAATATAATGTATA
AAACAGAATTTCATC
NB msaC F
GATTCCGATAATGATTTCTGGGATACTATTTT
NB msaB R
TAATACGACTCACTATAGGGTATAGTTTAACAACGTTT
GCAGCTTGTGGAC
NB msaB F
TTAAATGGTTTAACGCTGAAAAAGGATTCG
NB msaA R
TAATACGACTCACTATAGGGATAAAATATTTGTAAATC
CTCTTCACAATCTTCG
NB msaA F
GTGGACAGTTACCAAAATTAGAGCCGATTAT
RT msaC F
CCAGAAATCATTATCGGAATCACTA
RT msaC R
TTAGTTTTCGGTGTATTATCTGCAA
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Table 2.4 (continued).
Primers used in RT-qPCR
NB msaR F
NB msaR R
RT msaB F
RT msaB R
RT msaA F
RT msaA R
RT agrA F
RT agrA R
RT sarA F
RT sarA R
RT sigB F
RT sigB R
RT gyrA F
RT gyrA R

AATTAACCCTCACTAAAGGGAGCAGATGATTATTCCAT
ATTGCAAAGAAT
AATCTGAAACCTCCAAGACTACCCTTCATTCA
TTTATCGAAGTTGAAGGAGAAAATG
ACTCAACAGCTTGACCTTCTTCTAA
TCGATAACTATGTCACAGGCAAATA
TTGTAAATCCTCTTCACAATCTTCG
TTTGTCGTCAATCGCCATAA
TTTAACGTTTCTCACCGATGC
TTTGCTTCAGTGATTCGTTTATTTACTC
GTAATGAGCATGATGAAAGAACTGTATT
GAAGCTAAGTCTATCTCTTTATCGTGAA
CAAGAAATCGTTAAAGGCTTTGGTTATA
GCTCGTTCGTGACAAGAAAA
TTTGCATCCTTACGCACATC

Primer for operon deletion and complement
msaABCR upstr
GGGGACAAGTTTGTACAAAAAAGCAGGCTGCTTTAAAT
attB1 F
CAGCGATTAATGTTCGTTTG
msa operon upstr R ATGACTGGATCCTATTAAAGACCCCTTCCATACTTCAA
AAAC
msa operon dnstr F ATGACTGGATCCTTTCATGATGCTTGTTTAAAGTGTGGT
AT
msa operon dnstr
GGGGACCACTTTGTACAAGAAAGCTGGGTAGTTTGGAT
attB2 R
TATCAATTCAATATGGCTTAGC
msa operon F
TAAAATATCTGGATCCGACGCCTT
msa operon R
ATAAAGCTGCAGTCGTTAAGACAAC
msaC compl F
ACCGCGGTACCCAAGCTGCAAACGTTGTTAAACTA
msaC compl R
AAGCACGTGAATTCATAAAGCGACAATCGTTAA
msaABCR compl F GGGGGATCCTTTTACCACCTCATAATGTTAT
msaABCR compl R CCCGAATTCAAATAAACAAAGTAATCCCCGA
Primers for promoter activity
Pro-msaA F
CAATGCGGATCCTAAAATATCTAAATCCGACGCCT
Pro-msaA R
TCTGGCCAGGTACCGAATAACCACCATCCCTCATA
Pro-msaB F
TGCGAAGATGGATCCGAGGATTTACAAATATTTTA
Pro-msaB R
ACGTCATTGGTACCTTCAACTTCGATAAAGCC
Pro-msaR F
AATAAACAAAGGGATCCCCGAAGCACAGAAAATTA
Pro-msaR R
ACGCTGAAAAAGGTACCGGCTTTATCGAAGTTGAA
Pro-msaC F
AGGTCAAGGATCCGAGTTTGAAGTAGTTGAAGGCG
Pro-msaC R
CATTATCGGTACCACTAATACAATCATCATTGCTG
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Table 2.4 (continued).
Primers for promoter activity
Pro-sarAP1-F
Pro-sarAP1-R

ACTAGGGATCCCTGATATTTTTGACTAAACCAAATGC
ACTAGGGTACCGATGCATCTTGCTCGATACATTTG

Primers for frameshift point mutation
fsmut-msaC F1
ACTTGTAAATGGATCCGTCTCATTTTTACCACCTCA
fsmut-msaC R1
GCAGATAATACACCGAAACTAATAAATTAGCAACT
fsmut-msaC F2
AGTTGCTAAATTATTACTTTCGGTGTATTATCTGC
fsmut-msaC R2
AGTTATAAAGGTACCATCGTTAAGACAACTCATTA
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CHAPTER III
msaABCR NEGATIVELY REGULATES AUTOLYSIS AND BIOFILM
DEVELOPMENT IN STAPHYLOCOCCUS AUREUS
Abstract
Staphylococcus aureus is an important human pathogen that causes nosocomial
and community-acquired infections. One of the most important aspects of staphylococcal
infections is biofilm development within the host, which renders them resistant to the
immune response and antimicrobial agents. Biofilm development is very complex and
involves several regulators that ensure cell survival on surfaces within the extrapoylmeric
matrix. Previously, the msaABCR operon was identified as an additional positive
regulator of biofilm. In this study, the regulatory pathway that msaABCR uses to control
biofilm formation is defined. This study shows that the msaABCR operon is a negative
regulator of proteases. The control of protease production mediates processing of the
major autolysin Atl and therefore regulates rates of autolysis. In the absence of the
msaABCR operon, Atl is processed by proteases at a high rate, which leads to increased
cell death and a defect in biofilm maturation. This study concludes that the msaABCR
operon plays a key role in maintaining the balance between autolysis and growth within
staphylococcal biofilm.
Introduction
Staphylococcus aureus is a gram-positive human pathogen that causes nosocomial
and community-acquired infections, thus offering a new challenge in the treatment
processes because of their increasing prevalence of antibiotic resistance. In addition, S.
aureus is a biofilm-producing pathogen that causes implant-associated infections in the
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host. Biofilm formation allows this pathogen to avoid host immune response and
establish chronic infections like osteomyelitis and infective endocarditis. Besides, they
can also cause indwelling medical device associated infections and chronic wound
infections, which are also related to their ability to form biofilm. Despite the significant
amount of research on biofilm, the molecular mechanism for biofilm formation and the
associated global regulatory networks are still poorly understood. S. aureus produces a
very well-organized multilayered, three-dimensional mushroom shaped biofilm
embedded in the extrapolymeric proteinaceous slime layer composed of PNAG,
extracellular DNA, and several heterogeneous proteins. Studies have shown that proteins,
extracellular DNA, and/or polysaccharide intercellular adhesion (PIA) are major
contributors to the biofilm matrix (Cramton et al., 1999; Cramton et al., 2001; Houston et
al., 2011; Merino et al., 2009; Rice et al., 2007; Whitchurch et al., 2002). This
extracellular biofilm matrix helps biofilm to sequester and concentrate the environmental
nutrients and also provides an ability to resist external antimicrobial compounds and
evade host clearance strategies like phagocytes, shear stress, and host proteases. The cells
growing in biofilm includes diverse population with different metabolic states like
aerobic, fermentative, dormant, and dead cells depending upon the location of cells. The
majority of the cells inside the biofilm are dormant and in anoxic condition. This is the
main reason that makes them tolerant to high concentration of antimicrobials.
Several Transcriptional regulators like stress response sigma factors B (sigB),
Staphylococcal accessory regulator A (sarA), arlRS, and accessory gene regulator (agr)
quorum-sensing systems are the major players of regulating biofilm formation (Archer et
al., 2011; Beenken et al., 2003; Boles & Horswill, 2008; Boles & Horswill, 2011; Kullik
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et al., 1998; Novick, 2003; O'Gara, 2007; Tsang et al., 2008). Several biofilm regulating
operons like icaADBC, dtlABCD, cidABC, and psmβ also regulate the biofilm formation
(Gross et al., 2001; Heilmann et al., 1996; Otto, 2013; Rice et al., 2007; Vuong & Otto,
2002). Other factors like secreted proteases, eDNA, major autolysin (atl), and nucleases
also plays major role in the maintenance and dispersion of biofilm (Beenken et al., 2012;
Chen et al., 2013; Houston et al., 2011; Kiedrowski et al., 2011; Qin et al., 2007; Rice et
al., 2007).
Despite the wide knowledge of so many regulators and factors involved in biofilm
development, the potential therapeutic target effective for the treatment of biofilm
associated infection is still under question because of a lack of consensus in the
regulation of biofilm development among the diverse staphylococcal strain and straindependent regulation of biofilm development. Indeed, studies have shown that
staphylococcus strains regulate biofilm formation in PIA dependent, PIA independent,
and eDNA dependent mechanisms (Allesen-Holm et al., 2006; Cramton et al., 1999;
Cramton et al., 2001; Fitzpatrick et al., 2005; Mann et al., 2009; Rice et al., 2007;
Toledo-Arana et al., 2005; Whitchurch et al., 2002).
Previously, the new operon, msaABCR, is defined which comprised of two noncoding RNAs, msaC and anti-sense RNA (msaR) that is essential for the regulation of
msaABCR operon. The msaABCR operon regulates fundamental phenotypes in S. aureus
such as biofilm development and virulence (Sahukhal & Elasri, 2014). The msaABCR
operon also regulates the expression of the key global regulators sarA, agr, and sigB
(Sahukhal & Elasri, 2014). The mechanism of regulation of by the msaABCR operon is
not yet defined.
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Several studies have investigated the role of sarA, agr, and sigB in the biofilm
formation. The DNA-binding protein, SarA is a global regulator of virulence and
positively regulates the expression of biofilm associated proteins (bap) and icaADBC
locus and negatively regulates secreted proteases and nucleases which are detrimental to
biofilms (Beenken et al., 2010; Tsang et al., 2008; Valle et al., 2003). However, the
environmental signals that modulate the expression of SarA or its activity are not known.
Inactivation of sarA leads to a reduction in biofilm formation (Beenken et al., 2003) and
to attenuation in several animal disease models (e.g., septic arthritis (Blevins et al.,
2003), osteomyelitis (Booth et al., 1997), and endocarditis (Xiong et al., 2006)). Another
important global regulator is the alternative sigma factor sigB, which responds to
environmental stress during stationary growth phases (Gertz et al., 2000; Kullik &
Giachino, 1997; Palma & Cheung, 2001; Wu et al., 1996). sigB regulates its targets via
other regulatory genes or by acting directly on the promoters of virulence genes. sigB
positively regulates the expression of sarC and negatively regulates agr, but its effect on
sarA is not yet known (Bischoff et al., 2001; Deora et al., 1997; Horsburgh et al., 2002).
The regulator, sigB plays role in the biofilm formation. The effect of sigB is due to the
overexpression of secreted proteases. sigB controls the secreted proteases as a result of
repressive effect on the agr system (Bischoff et al., 2004; Lauderdale et al., 2009; PaneFarre et al., 2006). The agr system, another important global regulator, down-regulates
cell wall-associated adherence factor genes, thus, leading to decreased initial adherence
for biofilm formation; however, the major effect is via auto-inducing peptides (AIP) that
results into biofilm disassembly in protease dependent manner when the agr system is
repressed. Agr has also been shown to regulate the surfactant like peptides and nucleases
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that play roles in biofilm dispersal (Boles & Horswill, 2008; Novick, 2000; Novick,
2003; Yarwood et al., 2004). Studies have also shown that sarA is epistatic to agr during
biofilm formation (Beenken et al., 2010; Cassat et al., 2006).
Materials and Methods
Bacteria and growth conditions
Staphylococcus aureus strains Community Acquired MRSA strain
USA300_LAC, Restriction Deficient laboratory strain RN4220, and E. coli strain DH5α
were used in this study. S. aureus strains were grown in TSB. Antibiotics
(chloramphenicol (10 μg/ml), erythromycin (10 μg/ml) and kanamycin (50 μg/ml) were
used in TSB or TSA where needed. Similarly, E. coli strains were grown in LB broth
with Ampicillin (100 μg/ml) where needed. The details about strains and plasmid
constructs used in this study are listed on Table 3.1. All the primers used in this study are
listed on Table 3.2.
Construction of double deletion mutants
A previously described mutagenesis protocol was used (Bae & Schneewind,
2006; Sahukhal & Elasri, 2014) to construct a nonpolar, in-frame deletion of
msaABCR in LAC 13C (Δatl) strain (kindly provided by Drs. Jeffrey Bose and Kenneth
Bayles (Bose et al., 2012) and LAC proteases mutant (kindly provided by Dr. Mark
Smeltzer (Zielinska et al., 2012) to make LAC msaABCR/atl mutant and LAC
msaABCR/protease mutant, respectively. The deletion of msaABCR operon in LAC 13C
(Δatl) and LAC protease mutants was verified by end-point and real-time PCR as
described previously (Sahukhal & Elasri, 2014). The agr locus of the respective double
knockout mutants was also sequenced and compared it to the parent strain to ensure that
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it had not spontaneously mutated during the deletion procedure (McNamara & Iandolo,
1998; Villaruz et al., 2009).
Biofilm assays
The microtiter biofilm assay was performed as described previously (Sahukhal &
Elasri, 2014; Sambanthamoorthy et al., 2008). In brief, overnight cultures of cells were
diluted 1:100 times in TSB supplemented with 3% NaCl and 0.25% glucose and
inoculated in microtiter plates pre-coated with 20% human plasma. Cultures were
incubated for 24 or 48 h with shaking at 150 rpm. The adherent biofilm was quantitated
at 615 nm after washing and staining with crystal violet and elution with 5% acetic acid.
Mean values from a minimum of three independent experiments, each performed in
triplicate, were recorded. To study the effect of Polyanethole sulfonate (PAS) treatment
in the biofilm formation, the biofilm was grown in biofilm media in presence of 500
μg/ml of PAS as previously described (Rice et al., 2007).
Confocal Microscopy of Biofilm
Biofilms were grown on 96-well Cornings High Content Imaging Bottom
microplates as described previously (Sahukhal & Elasri, 2014; Sambanthamoorthy et al.,
2008). In brief, overnight cultures of cells, including wild type, mutant, and the
complemented strain of USA300 LAC were diluted 1:100 times in TSB supplemented
with 3% NaCl and 0.25% glucose and inoculated in microtiter plates pre-coated with
20% human plasma. Cultures were incubated for 48 h with shaking at 150 rpm. The
adherent biofilm was washed three times with sterile 1X PBS and stained with 50 μl of
live/dead stain (Syto-9 [1.3 μm] and Toto-3 [2.0 μm]) prepared in 1X PBS as previously
described (Mann et al., 2009). The biofilm images were taken by confocal microscopy
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(Zeiss 510 Meta CLSM) under a 40x/1.4 oil DIC objective. The Syto-9 stain was excited
with an argon laser at 488 nm, and the emission band-pass filter used for Syto-9 was 515
± 15 nm. The Toto-3 stain was excited using a HeNe 633-nm laser and emissions were
detected using a 680 ± 30-nm filter. Z-stacks were collected at 1.0 μm intervals. Images
obtained by confocal laser scanning microscopy (CLSM) were processed using
COMSTAT software to quantify total biomass, surface-to-volume ratio, thickness, the
number of dead cells, and the amount of eDNA (Heydorn et al., 2000).
Autolysis assay
Autolysis assays were performed as described by (Mani et al., 1993). Briefly,
overnight cultures of S. aureus were diluted to an OD600 of 0.05 in TSB containing 1 M
NaCl and allowed to grow at 37 °C with shaking until an OD600 of 0.7 was reached. Cells
were harvested by centrifugation, washed twice with ice-cold water, and then
resuspended in the same volume of 0.05 M Tris-Cl (pH 7.2) containing 0.025% Triton X100. Cells were then incubated at 30 °C with shaking. Absorbance (OD580) was measured
every 30 minutes to quantitate lysis. To assess the effect of protease inhibitors on
autolysis, the cells were first grown in TSB containing 1 M NaCl up to an OD580 of 0.1
and then protease inhibitors (protease inhibitor cocktail from Roche; and
phenylmethanesulfonylfluoride, PMSF, at 5 μm) were added. The cells were further
grown to an OD580 of 0.7, and autolysis assays were performed as above. All of the
experiments were repeated three times, and statistical significance tests (Paired t-test)
were performed using GraphPad software.
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Murein hydrolase assays
Assays for cell wall hydrolysis by extracellular murein hydrolases were
performed as described by (Groicher et al., 2000) with minor modifications. Briefly,
overnight S. aureus cultures were diluted 1:100, inoculated into Erlenmeyer flasks
containing 50 ml NZY broth and grown for 3 h at 37 °C and 220 rpm. The cells were
then diluted to an OD600 of 0.05 into a 50 ml of fresh NZY broth and grown for 4 h at 37
o

C with shaking at 220 rpm. The culture supernatant was harvested by centrifugation for

10 min at 5000 xg and filter-sterilized. The murein hydrolase assays were carried out in
50 ml flasks containing 0.05 M Tris-Cl (pH 8.0), 20 ml of supernatant and autoclaved
RN4220 cells (1.0 OD580). The final volume was adjusted to 25 ml, the flask incubated at
37 °C with shaking (200 rpm), and the turbidity (OD580) measured every 20 min.
Zymographic analysis
Zymogram analyses of extracellular, cell-wall bound and intracellular murein
hydrolases were performed as previously described (Mani et al., 1993). Crude cell wall
extracts were prepared from cells grown to mid-exponential phase by boiling in 4%
sodium dodecyl sulfate (SDS), and then washing with hot water to remove SDS. Cellwall bound autolysins were isolated by a freeze-thaw method as described previously
(Mani et al., 1993). Briefly, cells were resuspended in the 0.05M potassium phosphate
buffer (pH 7.2) and frozen at -80 °C for 1 h. The cells were then thawed in a 37 °C water
bath for 10 min. The freeze-thaw steps were done twice. Cells were then removed by
centrifugation and the supernatant containing the cell-wall bound autolysins was
collected. Intracellular autolysins were isolated by lysing cells using a Fast-Prep highspeed benchtop homogenizer. Cell debris was removed by centrifugation, and the
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supernatant was collected to assay for autolysin activity. Extracellular autolysins were
isolated by centrifugation of whole-cell cultures and collecting the supernatant, which
was then used for zymographic analysis. The enzyme extracts were concentrated using
Amicon Ultracel-3K centrifugal filters. The proteins were quantitated using a Quick
StartTM Bradford reagent.
Zymographic analysis was done using a 10% polyacrylamide-SDS gel containing
0.2% (wt/vol) crude cell walls from S. aureus (RN4220) or Micrococcus luteus. The
enzyme extracts (3 μg) were mixed with the loading buffer and heated for 3 min in a
boiling water bath prior to electrophoresis. After electrophoresis, the gel was washed
twice with water and incubated in renaturation buffer (25 mM Tris-HCl (pH 8.0)
containing 1% Triton X-100) overnight at 37 °C. Lytic activities were observed as clear
bands in the opaque gel. Gels were stained with 1% methylene blue in 0.01% KOH prior
to photography. The bands were quantified using myImageAnalysisTM v1.0 software
(2012) from Thermo Scientific.
Lysostaphin, mutanolysin, and lysozyme tolerance
Overnight-grown cells were diluted to an OD600 of 0.05 in TSB and allowed to
grow at 37 °C with shaking to an OD600 of 0.7. Cells were harvested, washed twice with
ice-cold water, and resuspended in the same volume of 0.05 M Tris-Cl (pH 7.2)
containing 2 μg/ml lysostaphin, 10 U/ml mutanolysin, or 10 μg/ml of lysozyme. Cells
were incubated at 37 °C with shaking, and lysis was measured by absorbance at OD600.
Quantification of eDNA Release in Biofilm
The amount of eDNA present in biofilm was quantified using RT-qPCR as
described previously (Rice et al., 2007). Four chromosomally encoded genes were used
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for this analysis: gyrase (gyr), 2-isopropylmalate synthase (leuA), ferrichrome transport
ATP-binding protein A (fhu), and diaminopimelate decarboxylase A (lysA) (Rice et al.,
2007). Results were reported as a copy number of eDNA relative to biomass.
RNA Isolation and Real-time qPCR
Total RNA was isolated from cells using a Qiagen RNeasy Maxi column (Qiagen)
as previously described (Sambanthamoorthy et al., 2006). Briefly, overnight cultures of
S. aureus were diluted to an OD600 of 0.05 in TSB and incubated at 37 °C with shaking
(200 rpm) until they reached an OD600 of 1.5. Real-time quantitative PCR (RT-qPCR)
was done as described previously (Sambanthamoorthy et al., 2006). All experiments were
done in triplicate. The constitutively expressed gyrase gene (gyr) was used as an
endogenous control (Goerke et al., 2000). Expression analysis for each gene was based
on at least two independent experiments. Two-fold or higher changes in gene expression
were considered significant.
Construction of proteases promoter–LuxAB fusions and luciferase assays
The E. coli–staphylococcal shuttle vector pCN58, which contains the low-copynumber staphylococcal replicon cassette (pT181copwt repC) and a promoterless reporter
gene, luxAB (encoding the luciferase from Vibrio ficheri) for transcriptional fusions
(Charpentier et al., 2004), was used for the study. The promoter region of the four
different proteases, (aureolysin (aur), staphopain (scp), cysteine (ssp) and serine (spl))
were fused with the luxAB as previously described (Sahukhal & Elasri, 2014). To study
the promoter–luciferase activity, overnight bacterial cultures were diluted 1:10 in TSB
and further incubated for 3 h. Cells were then normalized to OD 0.05 and further
incubated at 37 °C with shaking (220 rpm). Bacterial cells (5 ml) were harvested at
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different optical densities (OD600 of 0.7, 1.5, and 4.0) representing early-exponential,
mid- and late-exponential stages, respectively. The cells were washed once with 1X PBS
and resuspended in 1ml of 1X PBS. Cell suspension was mixed with 100 μl of 1%
decanal (v/v) in 90% ethanol, and luminescence was measured immediately after mixing
using a luminometer, based on a 10-s measurement in the integrated data mode. The cells
were also harvested from the 24 h, 48 h, and 72 h biofilms to study the proteases
promoter activity in the biofilm conditions. Luciferase activity was recorded as relative
luminescence units (RLUs), and the specific luciferase activities were calculated by
dividing the RLU values by the absorbance of the organism (RLU/OD600). The promoterless version of the reporter gene plasmid (pCN58) was used as a control in reporter gene
assays.
Proteases assay
Protease activity was measured from the supernatants of 4h and overnight cultures
as previously described (Sahukhal & Elasri, 2014; Sambanthamoorthy et al., 2006).
Briefly, 300 μl of the culture supernatant was mixed with 800 μl of 3 mg azocasein
ml−1 in Tris-buffered saline (pH 7.5) and incubated overnight at 37 °C. Undegraded
azocasein was precipitated by adding 400 μl of 50 % (w/v) trichloroacetic acid, removed
by centrifugation, and the amount of acid-soluble azocasein was determined by
measuring A340. All the experiments were performed at least three times, each in
triplicates.
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Results
Deletion of the msaABCR operon leads to a defect in biofilm development
Previously, it was observed that deletion of msaABCR operon in S. aureus led to a
defect in biofilm formation. This study further investigated the mechanism behind this
phenotype. The biofilm formation by the msaABCR deletion mutant was observed by
confocal microscopy after staining with live/dead stain, Syto-9, and Toto-3. Syto-9 stain
was used to stain live cell green while toto-3 was used to stain dead cells, and
extracellular DNA (eDNA) red (Figure 3.1). The confocal microscopy image showed a
significant increase in localized cell death within the biofilm in the deletion mutant
relative to the wild type and the complemented mutant. The mutant biofilm also showed a
lack of mature biofilm towers. The Z-stack of the confocal images were also analyzed by
using COMSTAT Image analysis software and found that the msaABCR deletion mutant
biofilm was relatively thin (7 μm, compared to 44 μm by wild type) and dispersed with
only a 12% live cell biomass when compared to the wild type biofilm which was set as
100%). COMSTAT Image analysis also showed the presence of significantly more dead
cells and extracellular DNA (eDNA) in the msaABCR mutant relative to the wild type,
21% versus 3% (Figure 3.1). The complemented mutant showed a similar phenotype to
wild type (Figure 3.1). These results suggest that the defective biofilm in the msaABCR
mutant is due to an increased rate of cell death.
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Figure 3.1. Confocal Microscopy and COMSTAT analyses of Z-stack image of biofilm.
A) Wild type USA300 LAC biofilm and B) msaABCR deletion mutant biofilm after 48 h.
The Confocal Biofilm Image, after stained with syto-9 (live cells, green) and toto-3 (dead
cells and eDNA, red) was taken under 40 x/1.4 Oil DIC objective. C) Image analysis was
done using COMSTAT software. These images are representative of three independent
experiments with similar results. Scale bar represents 10 µm.

msaABCR deletion mutant biofilm has more eDNA
Indeed, many studies have shown while controlled cell death and a release of
extracellular DNA (eDNA) enhances the biofilm formation; unregulated cell death may
have detrimental effects on biofilm (Bayles, 2007; Bitoun et al., 2013; Boles et al., 2010;
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Chan et al., 2013; Qamar & Golemi-Kotra, 2012; Rice et al., 2007; Wen et al., 2006).
This study further investigated by measuring the amount of extracellular DNA released in
the medium as an indicator of cell death. The eDNA was harvested from the biofilm and
quantified by using real time quantitative PCR (RT-qPCR). Four chromosomallyencoded genes (i.e., gyr, fhu, leu, and lysA) was used in this study to quantify the eDNA
harvested from the biofilm (Rice et al., 2007). The results showed that the eDNA
harvested from the msaABCR mutant was significantly in higher amounts relative to the
wild type and the complemented mutant strains (Figure 3.2). This result also supports the
confocal microscopy observations and suggests that the msaABCR mutant cells die at a
higher rate.

Figure 3.2. Quantification of extracellular DNA (eDNA) from biofilm. eDNA was
isolated from 48 h biofilm. Unwashed biofilm were treated with dispersin B and
proteinase K for 1 h. The total eDNA present in each biofilm was quantified by RTqPCR, using specific primers for gyrase (gyr), 2-isopropylmalate synthase (leuA),
ferrichrome transport ATP-binding proteinA (fhu), and diaminopimelate decarboxylase A
(lysA). The values are expressed as a copy number of eDNA relative to biomass. Mean
values from a minimum of three independent experiments, each performed in triplicate
are shown with error bars.
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msaABCR mutant has increased rate of cell death
The rate of autolysis of the mutant in planktonic growth was measured and found
that in the presence of Triton-X 100, the msaABCR mutant lyses at a significantly higher
rate (20–25%) than a wild type and the complemented mutant (Figure 3.3), thus,
confirming that the msaABCR deletion mutant is defective in cell death. The change in
autolysis rate is statistically significant according to the Paired t-test (p-value < 0.0001),
which suggests that msaABCR negatively regulates autolysis in S. aureus.

Figure 3.3. Triton-X 100 induced autolysis assay. Rates of autolysis were measured
every 20 min till 1h and every 30 min after 1h at OD580 from the cells harvested at an
OD600 of 0.7 and resuspended in Lysis buffer (0.05 M Tris, pH-7.5 with .025% Triton-X
100) as described in materials and methods. Experiments were repeated at least three
times. The paired t test statistical analysis was done using GraphPad software. The
deletion msaABCR mutant lysed at a significantly higher rate (p-value < .0001) compared
to its wild type.

Polyanethole sulfonate (PAS) restores biofilm formation in msaABCR deletion mutant.
Further support for the role of cell death in the msaABCR operon defect was
obtained by the treatment of the strains with Polyanethole sulfonate (PAS). This chemical
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inhibitor of cell lysis reversed the mutant’s phenotype (Rice et al., 2007; Wecke et al.,
1986) (Figure 3.4).

Figure 3.4. Biofilm formation assay in the presence of Polyanethole sulfonate (PAS). The
biofilm was grown in biofilm media in the presence of 500 μg/ml of PAS for 48 h. PAS
was introduced after 6 h and 12 h of incubation, and the biofilm was let grow till 48 h.
The biofilm was quantitated after crystal violet staining. Experiments were repeated at
least three times. Values represent the average of three independent assays, which were
done in triplicates. Results are reported as the mean ± S.E.

The biofilm formation by the msaABCR deletion mutant was further examined by
using confocal microscopy after staining with live/dead stain, Syto-9, and Toto-3. Syto-9
stains live cell green while Toto-3 stains dead cell and extracellular DNA (eDNA) red
(Figure 3.5). The comparable amount of biofilm in the deletion mutant and the wild type
was observed. In the presence of PAS, the mutant defective biofilm was restored back to
the wild type level and also showed the restoration of mature towers, which was lacking
in the mutant. The Z-stack confocal images were also analyzed by COMSTAT Image
analysis software and found no significant difference among the live cells, dead cells, and
the biofilm thickness between the mutant and the wild type (Figure 3.5). These findings
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indicate that the msaABCR operon is involved in the regulation of autolysis, and this
might be responsible for the biofilm defect in the mutant.

Figure 3.5. Confocal microscopy and COMSTAT analyses of biofilm in the presence of
Polyanethole sulfonate (PAS). The biofilm was grown in biofilm media in the presence of
500 μg/ml of PAS for 48 h, and Confocal Images were taken as described earlier after
staining with syto-9 and toto-3. The results showed that the msaABCR defective biofilm
restored back to the wild type level both visually and by the COMSTAT analysis of the
biofilm. These images are representative of three independent experiments with similar
results. The scale bar represents 10 µm.
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Biofilm development defect in the msaABCR mutant is mediated by increased processing
of the major autolysin, Atl
The mechanism involved in the increased cell death in the msaABCR mutant was
examined. There are several well-studied mechanisms by which the cells are defective in
autolytic behaviors: like cell wall perturbations, altered production of murein hydrolases,
altered processing and mobilization of murein hydrolases, and altered expression of holin
and anti-holin protein producing genes like cidABC and/or lrgAB operon. The
susceptibility of the whole cell-wall fractions to lysostaphin, mutanolysin, and lysozyme
harvested from msaABCR mutant was tested. There was no significant difference
between the msaABCR mutant and the wild type suggesting that cell wall perturbation
was not responsible for the increased autolysis. The expression of all known murein
hydrolases genes (atl, lytM, lytM, sle1, lytX, lytY and lytZ) and regulators of autolysis
cidABC, lgrAB and lytSR operon genes was also measured. No significant change in the
expression of these genes was observed in the mutant relative to the wild type. These
findings indicate that the role of the msaABCR operon in autolysis is not due to cell wall
perturbations or regulation genes known to control cell death.
Previously, the authors showed that the deletion of msaABCR led to increased protease
activity (Sahukhal & Elasri, 2014). Other studies have shown that murein hydrolases
(e.g., atl) are targeted by proteases, which then affect the rate of autolysis in S. aureus
(Biswas et al., 2006; Horsburgh et al., 2002; Lauderdale et al., 2009; Rice et al., 2007).
Since the msaABCR operon does not regulate the expression of murein hydrolase genes,
the role of protease-mediated processing of the murein hydrolases was investigated role
in by zymography. The activity of murein hydrolases (cell-wall bound and extracellular
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fraction) was measured using whole cell, Micrococcus luteus and S. aureus (RN4220)
cells as substrate. M. luteus cells and S. aureus cells were used as a source of cell wall
substrate to find the various glucosaminidase (GL) specific and amidase (AM) specific
activities, respectively, as previously described (Bose et al., 2012; Oshida et al., 1995;
Wadstrom & Hisatsune, 1970). Murein hydrolase bands that appears prominent in the
zymogram, in which a S. aureus cell is used as substrate is considered amidases. These
bands will appear faint on zymogram, in which a micrococcus cell is used as a substrate.
Bands were considered glucosaminidases if they showed the opposite pattern (Bose et al.,
2012; Oshida et al., 1995; Wadstrom & Hisatsune, 1970). The msaABCR deletion mutant
showed a significantly altered patter of activity of amidases and glucosamnidases relative
to the wild type and the complemented mutant (Figure 3.6 and Figure 3.7). In the
zymogram using S. aureus as cell substrate, the msaABCR deletion mutant showed a
significantly higher number of bands that corresponded to amidases compared to the wild
type in (cell-wall bound and extracellular fractions (Figure 3.6 and Figure 3.7). Similar
pattern of activity for glucosaminidases was observed, using M. luteus cells as a substrate
in both cell-wall bound and extracellular fractions (Figure 3.6 and Figure 3.7).
Overall, the msaABCR mutant showed more processing of the murein hydrolases
as evidenced by the absence of high molecular weight bands and the presence of several
low molecular bands in the zymogram in comparison to the wild type (Figure 3.6 and
Figure 3.7).
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Figure 3.6. Extracellular Murein hydrolase Zymogram. Total proteins (3 µg) harvested
from extracellular fractions were separated in 10% SDS-PAGE gel containing S. aureus
or M. luteus cells as a substrate. Gels were incubated overnight in a renaturation buffer
and stained with methylene blue. The msaABCR deletion mutant showed a significantly
altered pattern of AM and GL specific bands in the zymogram.

Figure 3.7. Cell-wall bound Murein hydrolase Zymogram. Total proteins (3 µg)
harvested from cell-wall bound fractions were separated in 10% SDS-PAGE gel
containing S. aureus or M. luteus cells as a substrate. Gels were incubated overnight in
the renaturation buffer and stained with methylene blue. The msaABCR deletion mutant
showed a significantly altered pattern of AM and GL specific bands in the zymogram.
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The high molecular weight murein hydrolases bands correspond to major
autolysin (Atl) and its derivatives. Whereas, the low molecular weight murein hydroalses
bands may arise from lytM, Sle1, LytN, and LytH. Since there were no significant
differences in the transcription levels of all known murein hydrolase genes between the
wild type and the mutant, these findings suggested that the bands produced by the
msaABCR mutant were the result of increased processing of Atl. To investigate this
possibility, the msaABCR/atl double mutant was generated in this study.
This msaABCR/atl double mutant showed no murein hydrolase activity in any of
the fractions tested (Figure 3.8 and Figure 3.9). The msaABCR/atl mutant also showed no
increase in autolysis relative to the wild type (Figure 3.10). The production of
extracellular proteases in this double mutant was also tested. The msaABCR/atl double
mutant also produced significantly higher amount of proteases (Figure 3.11). These
findings support the conclusion that the observed murein hydrolases activity of the
msaABCR mutant is primarily due to Atl processing.
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Figure 3.8. Cell-wall bound murein hydrolase zymography of double mutants. The
presence and processing of murein hydrolases were assessed in the cell-bound and
extracellular fractions collected from the double mutants (msaABCR/atl and
msaABCR/proteases). Total proteins (3 g) were harvested from the cell-wall-bound and
extracellular fractions and separated in 10% SDS-PAGE gel containing S. aureus or M.
luteus cells as a substrate. The gels were incubated overnight in renaturation buffer and
stained with methylene blue.
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Figure 3.9. Extracellular murein hydrolase zymography of double mutants. The presence
and processing of murein hydrolases were assessed in the cell-bound and extracellular
fractions collected from the double mutants (msaABCR/atl and msaABCR/proteases).
Total proteins (3 g) were harvested from the cell-wall-bound and extracellular fractions
and separated in 10% SDS-PAGE gel containing S. aureus or M. luteus cells as a
substrate. The gels were incubated overnight in the renaturation buffer and stained with
methylene blue.
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Figure 3.10. Triton-X-100-induced autolysis assay of double mutants. Autolysis rates and
murein hydrolase production were assessed in the mutants msaABCR/atl (A) and
msaABCR/protease (B). Rates of autolysis were measured in cells harvested at an OD600
of 0.7. Measurements were made at OD580 every 20 min for 1 h and every 30 min
thereafter. The experiments were repeated at least three times. A paired t test was used in
the statistical analysis with the GraphPad software (p < 0.0001).
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Figure 3.11. Comparison of extracellular proteases in the msaABCR/at and
msaABCR/protease double mutants. The protease production was quantified from the
overnight culture. Values are shown as the percent activity relative to the wild type strain
USA300 LAC which was set as 100%. Values represent the average of three independent
assays which were done in triplicates. Results are reported as the mean ± S.E.

Deletion of proteases gene restores atl processing and Biofilm development
To determine the contribution of proteases in this process, the promoters of the
genes from four major extracellular proteases (Aur, Scp, Ssp and Spl) were fused with
luxAB. The luciferase assay from the msaABCR deletion mutant showed significantly
higher production of light relative to the wild type in all growth conditions tested (an
early, mid, late exponential, and biofilm) (Figure 3.12). This confirms the role of
msaABCR in the regulation of expression of the protease genes.
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Figure 3.12. Promoter activities of protease genes. The activities of the protease
promoters were measured in the wild type and msaABCR deletion mutant. Luciferase
activity (luxAB) was measured in three planktonic growth phases (an early, mid, late
exponential phases, and the biofilm). The vector pCN58 containing luxAB without a
promoter was used as the negative control (not shown). The results are the means of three
independent experiments, and each measurement was made in triplicate. Standard error
bars are shown.
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The msaABCR deletion was introduced into a LAC protease knockout strain and
murein hydrolases zymogram activity, autolysis, and biofilm formation was measured.
The msaABCR/proteases double mutant showed no evidence of the processing of the high
molecular weight murein hydrolases (Figure 3.8 and Figure 3.9). Based on these findings
and studies by others, the two bands produced by this mutant were presumed to
correspond to Atl (Bose et al., 2012; Grilo et al., 2014). The msaABCR/proteases double
mutant did not show any increase in autolysis activity or defect in biofilm formation
relative to the wild type (Figure 3.10 and Figure 3.13). These results indicate that the
msaABCR biofilm defect is mediated by the overproduction of proteases, which leads to
increased processing of murein hydrolases and increased cell death.

Figure 3.13. Biofilm formation assay in double mutants. The biofilms of msaABCR/atl
and msaABCR/protease double mutants were grown in biofilm media for 48 h. The
biofilm was harvested, stained with crystal violet, and quantitated. The biofilm formation
by the double mutants was compared with the wild type strains and is shown in the
figure. The results are the means of three independent experiments, and each
measurement was made in triplicate. Standard error bars are shown.
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Furthermore, the biofilm formation by the msaABCR/protease double deletion
mutant was examined using confocal microscopy after staining with live/dead stain, Syto9, and Toto-3. Syto-9 stains live cell green while Toto-3 stains dead cell and extracellular
DNA (eDNA) red (Figure 3.13). The comparable amount of biofilm in the double
deletion mutant and the wild type was observed. Inactivation of the proteases in the
msaABCR deletion mutant restored back the biofilm phenotypes to the wild type level
and also showed the restoration of mature towers, which was lacking in the mutant. The
Z-stack confocal images were also analyzed by COMSTAT Image analysis software and
found no significant difference between the live cells, dead cells, and the biofilm
thickness between the mutant and the wild type (Figure 3.13). These findings indicate
that the increase proteases are responsible for the increase processing of major autolysin
(Atl), which leads to the increased rate of cell death. This increased rate of cell death is
responsible for the biofilm defect in the msaABCR operon deletion mutant. Finally, the
amounts of extracellular DNA produced in the msaABCR/atl and msaABCR/protease
double mutant’s biofilm were quantified. The results showed that there were no
significant differences in the eDNA production among the double mutants compared to
the wild type. These results also showed that the increased production of eDNA in the
msaABCR deletion mutant is due to increased rate of cell death in the biofilm (Figure
3.14).
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Figure 3.14. Confocal microscopy and COMSTAT analysis of msaABCR/protease
double mutant biofilm. The biofilm was grown in biofilm media in the the presence of
500 μg/ml of PAS for 48 h, and Confocal Images were taken as described earlier after
staining with syto-9 and toto-3. The results showed that the msaABCR defective biofilm
restored back to the wild type level both visually and by COMSTAT analysis of the
biofilm. These images are representative of three independent experiments with similar
results. The scale bar represents 10 µm.
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Figure 3.15. Quantification of extracellular DNA (eDNA) from the double mutant’s
Biofilm. eDNA was isolated from 48 h biofilm. Unwashed biofilm were treated with
dispersin B and proteinase K for 1 h. The total eDNA present in each biofilm was
quantified by RT-qPCR, using specific primers for gyrase (gyr), 2-isopropylmalate
synthase (leuA), ferrichrome transport ATP-binding proteinA (fhu), and diaminopimelate
decarboxylase A (lysA). The values are expressed as a copy number of eDNA relative to
biomass. Mean values from a minimum of three independent experiments, each
performed in triplicate, are shown with error bars.

Discussion
The msaABCR operon is essential for biofilm formation in S. aureus (Sahukhal &
Elasri, 2014). In this study, the mechanism for the regulatory role of msaABCR in the
biofilm development is defined. This study have shown that the deletion of the msaABCR
results in an excessive production of proteases, which leads to increased processing of the
major autolysin Atl. This, in turn, leads to uncontrolled cell death that contributes to the
biofilm defect in the msaABCR mutant. These findings are supported by several studies
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that have shown that excessive autolysis results in biofilm instability and a want of
maturation which reduces the growth rate within biofilm and upsets the balance between
growth and detachment (Bitoun et al., 2013; Boles et al., 2010; Chan et al., 2013; Qamar
& Golemi-Kotra, 2012; Wen et al., 2006). Controlled cell death and the release of eDNA
are important to form a robust and mature biofilm in staphylococci and other organisms,
including Pseudomonas aeruginosa, Streptococcus intermedius, Streptococcus mutans,
and Enterococcus faecalis.
Several processes have been implicated in autolysis such as cell wall
perturbations, increased activity or expression of murein hydrolases, and regulation of
holin and anti-holin expression (Bayles, 2007; Groicher et al., 2000; Madiraju et al.,
1987; Perkins, 1980; Qin et al., 2007; Rice et al., 2003; Shockman & Holtje, 1994; Wang
et al., 1992). The msaABCR regulates autolysis by controlling the processing of Atl via
proteases. There was no evidence found regarding the involvement of msaABCR in cell
wall perturbation or in the regulation of expression of murein hydrolases; including the
Atl, or the cidABC/lrgAB system.
Processing of murein hydrolases by proteases has been shown in several studies
(Biswas et al., 2006; Horsburgh et al., 2002; Lauderdale et al., 2009; Rice et al., 2007).
Indeed, activity of murein hydrolases is modulated at multiple levels that include
transport, substrate modifications, environmental conditions, and proteolytic processing
(Bierbaum & Sahl, 1987; Cleveland et al., 1976; Holtje & Tuomanen, 1991; Madiraju et
al., 1987; Tobin et al., 1994; Wecke et al., 1986). In this study, two cell substrates, S.
aureus or M. luteus, were used to determine the specific class of murein hydrolases (AM
versus GL) that are regulated by msaABCR (Bose et al., 2012; Oshida et al., 1995;
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Wadstrom & Hisatsune, 1970). The bands produced in the zymogram by the msaABCR
mutant were determined to be the result of increased processing of Atl and not from other
low molecular weight murein hydroalses such as lytM, Sle1, LytN, and LytH (Figure 3.6,
Figure 3.7, Figure 3.8, and Figure 3.9). Indeed, this study found that the msaABCR
operon has no effect on their expression. The Atl pro-protein (134 kDa) contains an AMGL peptide that is attached to a pro-peptide (Bose et al., 2012; Grilo et al., 2014). The
pro-protein of major autolysin, Atl, is cleaved to yield a 117 kDa AM-GL peptide. This
peptide is further processed to give various AM intermediates (100 kDa, 81 kDa, 70 kda,
and 63 kDa) and GL intermediates that include a 55 kDa peptide and two more products
that are slightly greater than 35 kDa and lack the repeated domain. The 63 kDa Atl
fragment corresponds to mature AM band with two repeat domains (AM-R1-R2) and
slightly less than 55 kDa fragments corresponds to the GL with one repeat domain (GLR3). The high molecular weight zymogram bands (134 and 117 kDa) showed both AM
and GL activity, whereas smaller molecular weight zymogram bands (100, 81, 70, and 63
kDa) showed AM specific bands. The 55 kDa, and other smaller zymogram bands
showed GM specific activity. All these high and low molecular weight zymogram bands,
thus showed the different sequential order of Atl processing. The findings from this study
correspond to some of the previous observations by other studies and strongly suggest
that Atl is the main murein hydrolase that is affected by the deletion of msaABCR operon.
Further support for this conclusion was obtained by examining the msaABCR/atl double
mutant, which showed the complete absence of all the processing products of the murein
hydrolase zymogram bands as described above (Figure 3.8 and Figure 3.9).
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Previously, this study showed that the msaABCR operon regulates protease
production (Sahukhal & Elasri, 2014). In this study, the increased proteases to the
increase processing of Atl were studied (Figure 3.6, Figure 3.7, Figure 3.8, and Figure
3.9). This study has also shown that the msaABCR operon controls the expression of four
extracellular proteases (Aur, Scp, Ssp and Spl) in different growth phases including
biofilm (Figure 3.12). Atl is processed collaboratively by the serine protease Ssp and the
cysteine protease Spl (Rice et al., 2001). These serine and cysteine proteases modulate
the activity, stability, and translocation of Atl, and affect autolysis and biofilm
development in S. aureus (Biswas et al., 2006; Chen et al., 2013; Grilo et al., 2014;
Lauderdale et al., 2009; Rice et al., 2001; Schlag et al., 2010; Thomas et al., 2008).
Interestingly, the mechanisms that regulate this balanced protease production and
processing of Atl are not yet understood. The msaABCR operon is an additional regulator
that is involved in biofilm development via protease expression. The environmental
signals that this operon responds to are still unknown. Other regulators have been shown
to control biofilm development via proteases. For instance, sarA mutants are biofilm
negative due to the increased production of proteases (Beenken et al., 2010; Zielinska et
al., 2012). Similarly sigB also regulates biofilm formation in an agr/protease dependent
pathway (Lauderdale et al., 2009).
Conclusion
This study concludes that the msaABCR operon plays a key role in maintaining
the balance between autolysis and growth within biofilm. The msaABCR operon achieves
this balance by controlling the level of expression of proteases, which process the major
autolysin Atl. Cell death within biofilm is important for the production of eDNA which
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contributes to the stability of the biofilm matrix and ensures proper maturation of the
biofilm. However, excessive cell death inhibits growth within biofilm and prevents
maturation. The contribution of individual genes and mechanism by which msaABCR
regulates protease, autolysis, and biofilm still under the investigation. Results from this
study have elucidated the regulatory pathway that msaABCR operon plays in biofilm
associated infections.
Table 3.1
Strains and plasmids used in this study
Plasmids or
strains
Plasmids
pKOR1

pMOE 399
pCN34
pMOE 403
pCN58

pMOE 481
pMOE 482
pMOE 483
pMOE 498
pMOE 501
pMOE 448

Strains
RN4220
Micrococcus
luteus
LAC
MOE 401

Relevant Characteristics

Source

E. coli-S. aureus shuttle vector, ori(Ts)
inducible, secY antisense counterselection,
Ampr Cmr
pKOR1: Δ msa operon deletion construct
pT181-based low copy number E. coliStaphylococcal shuttle vector
pCN34-msaABCR operon :: msaABCR operon
complement
pT18-based E.coli-staphylococcal shuttle vector
that contains promoterless LuxAB as a reporter
gene for promoter-gene fusion.
pCN58-Promoter aur
pCN58-Promoter ssp
pCN58-Promoter scp
pCN58-Promoter spl
pCN58-Promoter
E. coli pCN51 vector with pCAD inducible
promoter

Dr. Bae

Restriction deficient mutant of 8325-4
ATCC No. 4698

NARSA
Sigma Aldrich

CA-MRSA USA300 strains
LAC :: Δ msaABCR deletion mutant

Dr Shaw
This study

This study
NARSA
This study
NARSA

This study
This study
This study
This study
This study
This study
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Table 3.1 (continued).
Plasmids or
strains
Strains
MOE 404

MOE 508
MOE 458
MOE 512
MOE 466
MOE 467
MOE 645
MOE 646
MOE 647
MOE 648
MOE 649
MOE 650
MOE 651
MOE 652
MOE 653

Relevant Characteristics

Source

LAC 401 :: pMOE403 :: msaABCR complement
into msaABCR deletion mutant
MOE 401/pCN34-vector control
LAC 13C (Δatl)

This study

LAC/proteases
msaABCR/atl mutant
msaABCR/protease mutant
msaABCR complement into msaABCR/atl mutant
msaABCR complement into msaABCR/protease
mutant
LAC :: pCN58-Promoter aur
LAC :: pCN58-Promoter scp
LAC :: pCN58-Promoter spl
LAC :: pCN58-Promoter ssp
MOE 401 :: pCN58-Promoter aur
MOE 401 :: pCN58-Promoter scp
MOE 401 :: pCN58-Promoterspl
MOE 401 :: pCN58-Promoterssp
LAC :: pCN58-vector control

This study
Dr Jeffrey Bose /K.
Bayles
Dr Mark Smeltzer
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Table 3.2
Lists of Primers used in this study
Primers

Sequence (5’ → 3’ end)

Primer for msaABCR deletion and complement
msaABCR upstr
GGGGACAAGTTTGTACAAAAAAGCAGGCTGCTTTAAA
attB1 F
TCAGCGATTAATGTTCGTTTG
msaABCR upstr R
ATGACTGGATCCTATTAAAGACCCCTTCCATACTTCAA
AAAC
msaABCR dnstr F
ATGACTGGATCCTTTCATGATGCTTGTTTAAAGTGTGG
TAT
msaABCR dnstr
GGGGACCACTTTGTACAAGAAAGCTGGGTAGTTTGGA
attB2 R
TTATCAATTCAATATGGCTTAGC
msaABCR compl F GGGGGATCCTTTTACCACCTCATAATGTTAT
msaABCR compl R CCCGAATTCAAATAAACAAAGTAATCCCCGA
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Table 3.2 (continued).
Primers

Sequence (5’ → 3’ end)

Primers for proteases promoter activity
Pro-aur F
TTGATTAGGATCCTTTAAATAGTTATCTCACATATTT
Pro-aur R
ACAGCTTATAGGTACCATATTAATTTAATTTTTCAGAA
Pro-ssp F
ATATATCAGGATCCATATTAATCTACCTTTGGCCAA
Pro-ssp R
AACCTACAAAGGTACCATTTACAAGTTAAATATAACA
Pro-scp F
GTTGTTGGATCCGTGTGGCATTTTAAATATAAGAC
Pro-scp R
ATATAAGGTACCCTTTATTTTATTATAAAATAATTATAT
TAAATT
Pro-spl F
ATAATAGGGGATCCAATCGCTAATAATGTTGTTAA
Pro-spl R
TTTACCTGGTACCAAATTTATTTTTATAGTTAATGT
Primers for Real time PCR
RT gyrA F
GCCGTCAGTCTTACCTGCTC
RT gyrA R
AATAACGACACGCACACCAG
RT fhuA F
ATGAATCGTTTGCATGGACA
RT fhuA R
GTAACTTCCATTGCCCAATC
RT leuA F
TTTTGATACGACACTAAGAGACGG
RT leuA R
GCGTATGTGACATGTTCTTTAATAG
RT lysA F
AAATGGCGAATTAACAATGGATGG
RT lysA R
TACCATGGAAATGGATGCGA
RT atl F
TTTGAGTCGTTTTAACTTCTTTGCC
RT atl R
ACAATACAAGCCATAACATCCCATT
RT lytM F
TCAAAATGGTGGATCAGCAA
RT lytM R
CACCACCGTGATATTGTCCA
RT lytN F
TTTGGTGGAGGATATGGTCA
RT lytN R
GCCATCCACCATTATTCCAG
RT sle1 F
ACATGGGGTCAATGTACATATCATG
RT sle1 R
CGTTATCCCAGTTATTAGCATTCCA
RT lytX F
TCCCAACCATGCTTTTTAGC
RT lytX R
GAGTCGAAATTGATGGCAAA
RT lytY F
GATGTTGCGCAGGATTTTCT
RT lytY R
CGATTATTGGTGGTGCAAAG
RT lytZ F
CCGAAAATATCCAAGCACGA
RT lytZ R
TCCGATTTCCATGTTGGTTT
RT cid F
TTTAGCGTAATTTCGGAAGCA
RT cid R
GGGTAGAAGACGGTGCAAAC
RT lrg F
GCATCAAAACCAGCACACTTT
RT lrg R
TGATGCAGGCATAGGAATTG
RT lytSR F
AAGAAACATTGGAAGCACTACTGAT
RT lytSR R
GAATCTTAGCTCCTAATTCGATCCC
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